Resistance to Bordetella bronchiseptica infection in swine by Harris, Delbert Linn
Retrospective Theses and Dissertations Iowa State University Capstones, Theses andDissertations
1970
Resistance to Bordetella bronchiseptica infection in
swine
Delbert Linn Harris
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/rtd
Part of the Animal Sciences Commons, and the Veterinary Medicine Commons
This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University
Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University
Digital Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Harris, Delbert Linn, "Resistance to Bordetella bronchiseptica infection in swine " (1970). Retrospective Theses and Dissertations. 4313.
https://lib.dr.iastate.edu/rtd/4313
71-7274 
HARRIS, D.Y.M,, Delbert Linn, 1943-
RESISTANCE TO BORDETELLA BRONCHISEPTICA 
INFECTION IN SWINE. ' 
Iowa State University, Ph.D., 1970 
Veterinary Sciences 
University Microfilms, Inc., Ann Arbor, Michigan 
THIS DISSERTATION HAS BEEN MICROFILMED EXACTLY AS RECEIVED 
RESISTANCE TO BORDETELLA BRONCHISEPTICA 
INFECTION IN SWINE 
by 
Delbert Linn Harris, h.VAL 
A Dissertation Submitted to the 
Graduate Faculty in Partial Fulfillment of 
The Requirements for the Degree of 
DOCTOR OF PHILOSOPHY 
Major Subject: Veterinary Microbiology 
Approved: 
In Charge of #ajor Wor^ 
Head of Major Department 
irisiof Gi/adi Dearisi aduate College 
Iowa State University 
Ames, Iowa 
1970 
Signature was redacted for privacy.
Signature was redacted for privacy.
Signature was redacted for privacy.
ii 
TABLE OF CONTENTS 
Page 
INTRODUCTION 1 
REVIEW OF THE LITERATURE 5 
Cultural Characteristics of Bordetella 
bronchiseptica 5 
Bordetella bronchiseptica Infection in 
Swine 11 
Resistance of Various Animals to Bordetella 
bronchiseptica and Bordetella pertussis 19 
Respiratory Tract Resistance to Infectious 
Agents 31 
Natural resistance 31 
Acquired resistance 34 
MATERIALS AND METHODS 37 
Source of Bordetella bronchiseptica and 
Bordetella pertussis Isolates 37 
Source of Pasteurella multocida and 
Haemophilus spp. Isolates 38 
Culture Media 38 
Bordetella bronchiseptica Inocula 39 
Respiratory Tract Inoculations 40 
Identification of Bordetella bronchiseptica, 
Pasteurella multocida, and Haemophilus spp. 41 
Preparation of Buffered Solutions 41 
Phosphate buffered saline (PBS) 41 
Veronal buffered diluent (VBD) 42 
Preparation of Vaccines 42 
Sonicate-vaccine 42 
Pertussis-vaccine 44 
Whole cell-vaccines 45 
iii 
Source and Care of Experimental Swine 46 
Animal Experiments 47 
Collection of Specimens 48 
Histological Procedures 49 
Antigens 52 
Bordetella bronchiseptica broth antigens 52 
Bordetella bronchiseptica agar antigens 53 
Bordetella pertussis antigen 53 
Salmonella spp. antigens 54 
Antisera 54 
Swine antisera 54 
Rabbit antisera 55 
Identification of antisera sample numbers 55 
Serologic Tests 57 
Particulate antigen settling test (PAST) 57 
Microagglutination test (MAT) 61 
Tube agglutination test 61 
Plate agglutination test 62 
Direct hemagglutination inhibition test 
(HAD 62 
Opsonocytophagic test 64 
Bactericidal test 65 
Agglutination of Erythrocytes and Epithelial 
Cells 66 
Phagocytosis of Bordetella bronchiseptica 67 
Statistical Analysis 67 
RESULTS 68 
Swine Experiments 68 
Infection of the swine nasal cavity with 
virulent Bordetella bronchiseptica (B 
strain) and clearance by sulfonamide 
therapy to induce resistance 68 
Infection of the swine nasal cavity with 
low-virulence Bordetella bronchiseptica 
(D-1 strain) and recovery from infection 
by natural elimination to induce resistance 70 
iv 
Subcutaneous injection of swine with either 
sonicly disrupted Bordetella bronchiseptica 
(D~l strain) vaccine or pertussis-vaccine 
to induce respiratory resistance 88 
Injection of swine with formalized whole cell 
Bordetella hronchiseptica vaccines to 
induce respiratory resistance 104 
Subcutaneous injection of pregnant sows with 
sonicly disrupted Bordetella bronchiseptica 
(D-1 strain) vaccine to induce respiratory 
resistance in newborn pigs 105 
Respiratory resistance to Bordetella 
bronchiseptica associated with age of 
swine at the time of first intranasal 
exposure 111 
Serologic Tests 113 
Development of the particulate antigen 
settling test (PAST) 113 
Direct hemagglutination inhibition test 124 
Opsonocytophagic test 124 
Bactericide! test 128 
Agglutination of Erythrocytes and Epithelial Cells 129 
Phagocytosis of Bordetella bronchiseptica 133 
DISCUSSION 134 
ACKNOWLEDGEMENTS 161 
BIBLIOGRAPHY 163 
1 
INTRODUCTION 
In 19 56, it was reported that pure cultures of Bordetella 
bronchiseptica, when instilled into the nasal cavities of young 
experimental swine, would cause turbinate hypoplasia and 
pneumonia. Research in swine respiratory diseases since 19 56 
has shown B. bronchiseptica to be the main etiologic factor in 
the disease commonly called atrophic rhinitis. 
During the past decade, Bordetella rhinitis has been well 
characterized. Studies on the pathogenesis of Bordetella 
rhinitis have shown that experimental infection of swine, 4 
weeks of age or less, readily produces turbinate hypoplasia by 
2-5 weeks postinoculation. Microscopic changes include hyper­
plasia and metaplasia of the pseudostratified ciliated columnar 
epithelium, cilia swelling and loss, infiltration of neutrophils 
and mononuclear leucocytes into the lamina propria, submucosal 
fibroplasia, and osseous resorption and replacement fibrosis. 
The B. bronchiseptica organisms remain upon the epithelial cell 
surface and do not invade the submucosa. 
Pathogenicity for pigs of various isolates of B. bronchi­
septica has been compared. Intranasal inoculation of 4 
isolates of swine origin, an isolate of rabbit origin, an 
isolate of cat origin, and an isolate of rat origin caused mild 
to moderate turbinate hypoplasia in experimental swine. An 
isolate of dog origin caused no turbinate hypoplasia. This 
series of experiments helps explain the variation of the degree 
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of turbinate hypoplasia reported in some field outbreaks of 
rhinitis. Also,the possibility of other animal species serving 
as reservoirs of infection was illustrated. 
The role of Pasteurella multocida in rhinitis of swine has 
recently been more clearly elucidated. This organism occurs at 
a low incidence in the nasal cavities of North American swine. 
Canadian workers have demonstrated that P. multocida, serotype 
E, would cause rhinitis and turbinate hypoplasia by intranasal 
inoculation of swine with the organism. However, P. multocida, 
serotype D, is the most commonly occurring strain in the United 
States. Experimental infection of swine with serotype D was 
only accomplished by preconditioning the nasal cavity with B. 
bronchiseptica infection for 1 week. The dual experimental 
infection of the swine nasal cavity by both bacteria enhances 
the degree of turbinate hypoplasia as compared to the swine 
nasal cavity infected with B. bronchiseptica alone. 
In the early 1960's, bacteriologic examination of the nasal 
cavities of swine from herds affected with clinical signs of 
rhinitis revealed that B. bronchiseptica existed in 56 to 6 8 
percent of the herds surveyed. Progressive purebred and com­
mercial herds had an incidence ranging from 38 to 54 percent. 
Shortly after these surveys were conducted, it was discovered 
that certain sulfonamides (sulfamethazine and sulfaethoxypyri-
dazine] when added to the swine ration would clear B. bronchi­
septica infection from the swine nasal cavity in 3-5 weeks. 
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These sulfonamides have been incorporated with growth promoting 
antibiotics and have enjoyed wide popularity as feed additives 
to swine rations for the past several years. 
In 19 57, the nasal cavities of swine from 102 progressive 
Iowa swine herds were cultured bacteriologically. Results of 
this survey indicated that 25 percent of the herds had B. 
bronchiseptica and 9 percent had P. multocida. The isolates 
of B. bronchiseptica recovered from 20 herds (80 percent) were 
resistant to sulfonamide as determined by sensitivity disc 
assay. These results indicate that the decrease in the number 
of herds infected with B- bronchiseptica since 1962 may be 
attributed to the widespread use of sulfonamide as a feed addi­
tive. However, the incidence would probably be lower had not 
sulfonamide resistant strains of the organism appeared. 
According to the 196 7 survey, approximately 20 percent of the 
Iowa swine herds are infected with B. bronchiseptica which are 
resistant to sulfonamides. The presence of drug resistant 
strains of B. bronchiseptica indicates the need for either 
additional drugs with the ability to clear the organism from 
the nasal cavity or immunizing products for prevention of in­
fection . 
Recently it was demonstrated that a nasal resistance to 
reinfection with B. bronchiseptica could be induced in swine 
by either clearing the nasal cavity of a virulent strain infec­
tion by drug therapy or previous infection of the nasal cavity 
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with a low-virulence strain of the organism. After clearing 
the low-virulence strain (4-6 weeks after initial exposure) 
experimental swine were resistant to subsequent challenge to 
virulent strain for at least 95 days. 
In view of the need for methods of controlling Bordetella 
rhinitis, the present study was undertaken to investigate the 
mechanism by which respiratory resistance to B. bronchiseptica 
infection was induced in experimental swine and to evaluate 
possible application of these findings to the control of this 
disease. 
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REVIEW OF THE LITERATURE 
This literature review covers four areas: 1. Cultural 
Characteristics of Bordetella bronchiseptica, 2. Bordetella 
bronchiseptica Infection in Swine, 3. Resistance of Various 
Animals to B. bronchiseptica and Bordetella pertussis, and 
4. Respiratory Tract Resistance to Infectious Agents. Excel­
lent reviews by Winsser (1960) and Ross (1965) cover the 
history, bacteriology, and animal pathogenicity of B. bronchi­
septica; therefore, in this review only the more pertinent 
literature in these areas will be discussed. 
Cultural Characteristics of 
Bordetella bronchiseptica 
Bordetella bronchiseptica was placed in the genus Borde­
tella in both the seventh edition of Bergey's Manual of Deter­
minative Bacteriology (Breed et a2., 1957) and the fifth edition 
of Topley and Wilson's Principles of Bacteriology and Immunity 
(Wilson and Miles, 1964). Ferry (1910) was the first to iso­
late the organism. He names it Bacillus bronchicanis since it 
was isolated from the respiratory tract of dogs with distemper. 
After being found in the respiratory tract of a variety of 
animals. Ferry (1912a) renamed the organism Bacillus bronchi-
septicus. 
Prior to 1957, B. bronchiseptica had been placed in three 
different genera: Alcaligenes (Bergey, 1923), Brucella 
(Bergey et , 1939; Breed et ^., 1948), and Haemophilus 
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(Wilson and Miles, 1946, 1955). Inclusion in the genus 
Alcaligenes was based on morphologic, growth and biochemical 
similarities to Alcaligenes faecalis. Placement in the genera 
Brucella and Haemophilus was based on morphologic, growth, 
biochemical and antigenic similarities to m,eiribers of those 
genera. 
Ferry and Noble (1918) and Ferry and Klix (1918) reported 
the antigenic relationship of B. pertussis and B. bronchisop­
tica. Further studies have indicated close antigenic, mor­
phologic, and biochemical similarities between B. parapertussis, 
B. pertussis, and B. bronchiseptica (Eldering and Kendrick, 
1938; Bruckner and Evans, 1939; Eldering, 1941; Keogh et al., 
1947). These three species were classified in a new genus 
Bordetella by Moreno-Lopez (1952). Justification for this 
classification was further documented by Andersen (1952); 
Lacey (1953; Eldering et (1957); Sutherland and Wilkinson 
(1963); and Barber et a2. (196 7). 
Bordetella bronchiseptica grows as a pleomorphic slender 
rod in broth and as a coccoid rod on agar. The bacillary forms 
measure approximately 0.5 by 1.5 micron and the coccoid forms 
measure approximately 0.5 by 1 micron (McGowan, 1911; Torrey 
and Rahe, 1913; and Lautrop and Lacey, 1960). Ferry (1910, 
1911) reported that B. bronchiseptica was Gram negative and was 
bipolar when stained with Loeffler methylene blue. Evans and 
Maitland (1939) and Repentigny and Frappier (1956) demonstrated 
capsules on B. bronchiseptica. 
7 
Richter and Kress (1967) studied the fine structure of 
B. bronchiseptica and found it to have a cell wall composed of 
five layers, a trilaminar cell membrane, many ribosomes in the 
cell matrix, and nucleoidal material composed of fibrils and 
dense bodies. Ferry (1910), Smith (1913), and Torrey and Rahe 
(1913) found B. bronchiseptica to be motile by means of 
peritrichous flagella. Lautrop and Lacey (1960) and Ross (1965) 
reported that some strains of B. bronchiseptica are nonmotile. 
Using electron microscopy, Labaw and Mosley (1955) interpreted 
metal-coated preparations of flagella to exist in a counter­
clockwise or left-handed triple helix. By comparison,recent 
observations by Richter and Kress (1967), using both metal-
coating and negative staining techniques,have shown images of 
B. bronchiseptica flagella to exist as a "braided" structure. 
Negative contrast preparations indicated that 5 to 6 strands 
were interlaced to form each "braid" with a strand width of 20 
O O 
A. The flagella width ranged from 180 to 220 A. 
Torrey and Rahe (1913) reported that B. bronchiseptica 
alkalized carbohydrates and litmus milk but did not ferment 
carbohydrates; some strains reduced nitrates to nitrites, and 
the organism did not produce indole or hydrogen sulfide. Ross 
(1965) found that 17 of 60 strains reduced nitrates to nitrites. 
Szturm and Bourdon (1948) showed that B. bronchiseptica utilizes 
citrate as the sole source of carbon. Bradford and Slavin 
(1937) reported the organism produced catalase. Lautrop and 
Lacey (1960) and Farkas-Himsley (1963) found that B. bronchi-
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septica produced cytochrome oxidase, and the latter author 
observed it was lysine decarboxylase positive. Ulrich and 
Needham (1953) found that the organism required nicotinic acid 
for growth in a vitamin free synthetic medium and that B. 
bronchiseptica produced urease. This latter characteristic 
aids in the differentiation of B. bronchiseptica from 
Alcaligenes faecalis. 
Sutherland and Wilkinson (1963) reported that B. bronchi-
septica produces a "blue protein" called azurin which undergoes 
reduction in the presence of concentrated cell-free extracts 
of the organism and succinate. These workers postulated that 
azurin may act as an alternative in the electron-transport 
system between cytochrome c and cytochrome oxidase. 
Bordetella bronchiseptica has been reported to be beta 
hemolytic on the following types of blood agars: bovine (Ross 
e_t , 1963a), horse (L'Ecuyer et , 1961), sheep (Winsser, 
1960) , and rabbit, dog, and guinea pig (Torrey and Rahe, 1913). 
The organism does not produce hemolysis of washed rabbit, sheep, 
or human erythrocytes when incorporated in broth culture medium 
(Winsser, 1960). L'Ecuyer ejt al. (1961) reported that transfer 
of B. bronchiseptica in embryonated hens eggs increased the 
degree of hemolysis on horse blood agar. 
Three types of agglutinogens of B. bronchiseptica have 
been described: flagellar H antigens, heat labile K antigens, 
and heat stable 0 antigens (Eldering et al., 1957 and Lautrop 
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and Lacev/ 1960). Fourteen heat labile K antigens are shared 
by B. bronchiseptica, B. pertussis, and B. parapertussis t but 
each species contains at least one specific antigen. Differ­
entiation of species by heat stable 0 antigens has not been 
reported. Keogh et (1947) reported that whole B. bronchi­
septica cells, filtrates, and supernatants of broth cultures 
would cause agglutination of human, mouse, and fowl erythro­
cytes . This hemagglutinin was also present in B. pertussis 
and B. parapertussis cells and cultures. Bordetella bronchi­
septica was found to agglutinate sheep erythrocytes but not 
horse erythrocytes (Joubert et a2., 1960). Gallagher (1965) 
reported that an isolate of B. bronchiseptica from a horse 
agglutinated horse and parakeet erythrocytes. 
Eldering (1941) prepared lipopolysaccharides from the 
three Bordetella species by extraction of whole cells with tri­
chloroacetic acid. The lipopolysaccharides were toxic for mice 
and rabbits. Harris et a^. (1968) reported that lipopoly­
saccharides extracted with trichloroacetic acid from B. bronchi­
septica and b. pertussis were toxic for embryonated hens eggs 
and produced an inhibition of some of the energized processes 
of beef heart mitochondria ^  vitro. This lipopolysaccharide 
specifically acted by inhibiting oxidative phosphorylation at 
site 3 in complex IV but prevented electron transport just 
prior to complex IV in mitochondria. It is interesting to note 
that the azurin described by Sutherland and Wilkinson (1963) 
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may have the opposite activity of lipopolysaccharide in the 
electron transport system. Phenol extraction procedures were 
utilized to isolate lipopolysaccharides from the three species 
of Bordetella (Maclennan, 19 60). He found that Bordetella 
lipopolysaccharides were similar both chemically and bio­
logically to those of other Gram negative bacteria. Evans and 
Maitlar.d (1939) demonstrated a heat labile toxin in freeze-thaw 
extracts of B. bronchiseptica and B. pertussis. These pre­
parations were toxic to guinea pigs and caused dermonecrosis 
when injected subcutaneously into rabbits. The toxin was 
formalin sensitive, nonantigenic, and lost potency on filtra­
tion through a Seitz E K filter. Oddy and Evans (1940) reported 
that the heat labile toxin induced initial hyperglycemia and 
later hypoglycemia and death in rabbits. The hypoglycemia 
inducing factor was eliminated by heating the toxin at 55° C 
for 30 minutes. 
Rauch and Pickett (1961) reported that 38 bacteriophages 
were obtained from 4 8 strains of B. bronchiseptica as sponta­
neous mutants without ultraviolet induction. Ultraviolet 
exposure of lysogenic organisms failed to cause induction. 
Thirty-five of the 4 8 strains of B. bronchiseptica were sensi­
tive to at least one phage. Bordetella parapertussis was also 
sensitive to these phages; however, B. pertussis was not. 
Litkenhous and Liu (1967) isolated 2 bacteriocins from 24 
strains of B. pertussis which inhibited the growth of 20 strains 
of the same organism. These 2 bacteriocins were inactive on 
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B. bronchiseptica and B. parapertussis. 
Bordetella bronchiseptica has been commonly associated 
with diseases of the respiratory system in animals and on rare 
occasions, poultry. The organism has been isolated from the 
following; dogs (Ferry, 1910); humans, monkeys, goats, cats, 
rabbits, ferrets, and guinea pigs (McGowan, 1911); mice (Keegan, 
1920); swine (Dorset et , 1922); fox (Rosenow, 1931); rats 
(Bordon and Kulp, 1939); hedgehog (Edwards, 1957); horses 
(Gallagher, 1965); skunk, oppossum, and raccoon (Switzer et al., 
1966); and turkeys (Filion et aJ.. , 1967). Brown (1926) re­
ported isolation of B. bronchiseptica from a child with 
clinical symptoms of whooping cough. A rabbit was considered 
to be the source of infection for the child. Although B. 
pertussis has been the most consistent organism isolated from 
whooping cough in man, B. bronchiseptica has been found asso­
ciated with the disease occasionally. Estimates indicate that 
0.1 percent of the whooping cough cases in London were caused 
by B. bronchiseptica (Lautrop and Lacey, 1960). 
Bordetella bronchiseptica Infection in Swine 
The role of B. bronchiseptica in the respiratory disease 
complex of swine has only recently been elucidated and substan­
tiated. Early reports mention B. bronchiseptica or organisms 
with similar characteristics associated with pneumonia in swine 
(Dorset et al., 1922; Spray, 1922; and Thorp and Tanner, 1940). 
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Phillips (1943) considered B. bronchiseptica to be a signifi­
cant primary agent in swine pneumonia; the organism was isolated 
from swine on 7 farms in Ontario. Phillips (1944) reported in­
creased protection against hemorrhagic septicemia if B. bronchi­
septica and Pasteurella multocida antisera were administered 
to baby pigs at birth, A bacterin containing both organisms 
was used later. Betts (1952) recovered B. bronchiseptica from 
pneumonic swine lungs in England and considered the organism 
to be a secondary invader of virus pneumonia of pigs. Ray 
(1950) found B. bronchiseptica to be associated with pneumonia 
in swine in the United States and believed a bacterin contain­
ing the organism protected young pigs. Ray (1959) suggested 
the term porcine whooping cough for swine pneumonia caused by 
B. bronchiseptica and believed infected dogs served as a 
reservoir of infection for swine. 
Evidence that B. bronchiseptica is a primary cause of 
pneumonia in swine has been reported from France (Joubert et al., 
1960), United States (L'Ecuyer et a^., 1961, and Dunne et al., 
1961), England (Goodwin and Whittlestone, 1962 and 1964), and 
O 
Norway (Arskog, 1967). L'Ecuyer et (1961) reproduced 
pneumonia with B. bronchiseptica by a combination of intra­
tracheal and intranasal inoculations of the organism grown in 
embryonating chicken eggs. These workers described the macro­
scopic and microscopic changes occurring in this pneumonia at 
11 days postinoculation which included: a bluish tan colora­
tion to the pneumonic areas, hyperemia of the peribronchial 
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vessels, lymphocytic infiltration of the propriomucosa, and 
alveolar exudate consisting of neutrophils, lymphocytes, edema, 
and fibrin. Duncan et (1966a) described the lesions pro­
duced in experimental pigs following intratracheal inoculation 
with broth cultures of the organism. The pigs were necropsied 
at 2, 4, 6, 8, 12 days and 4 weeks postinoculation. Macro-
scopically,the color of the pneumonic areas changed from a 
dark red to brown to yellow to a greyish yellow as the interval 
postinoculation increased. The pneumonic areas became firm to 
palpation as the lesion became more chronic. Microscopically, 
early lesions were hyperemia with some alveolar hemorrhage. 
Fibrin was present in the interalveolar spaces which were 
swollen by edema. Neutrophils were present in the interlobular 
lymphatics and the lumens of the bronchi and bronchioles. 
Bacterial colonies were present on the mucosal surface. Meta­
plasia of the bronchiolar epithelium occurred by 6 days post-
inoculation. As the postinoculation interval increased, 
epithelialization of the alveoli occurred, adventitial fibro­
plasia of the bronchioles occurred, cellular exudate increased 
and the degree of hemorrhage and hyperemia decreased. 
Daugherty (1941) recovered B. bronchiseptica from the 
nasal cavities of pigs afflicted with rhinitis and observed 
that a clinical improvement could be obtained from administra­
tions of a mixed canine bacterin containing the organism. 
Phillips (1946) and Moynihan (1947) recovered B. bronchiseptica 
from the nasal cavities of swine with atrophic rhinitis. 
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Switzer (1956) presented evidence that various etiologic 
agents were involved in the production of atrophic rhinitis in 
swine. He found that a filter-passing agent (Selas No. 01 and 
0.5-0.75% cellulose membrane), Pasteurella multocida, or 
Alcaliqenes sp. would produce turbinate atrophy when instilled 
intranasally into young pigs. Claflin (195 8) reported that 
Alcaligenes faecalis would produce atrophic rhinitis. Later 
reports by Switzer (1959) and Cross and Claflin (1962) indi­
cated that the organism originally identified as Alcaligenes sp. 
was B. bronchiseptica. These workers produced atrophic rhinitis 
in pigs by instilling broth cultures of B. bronchiseptica into 
the nasal cavity. Cross and Claflin (1962) isolated the organ­
ism from pigs with atrophic rhinitis within 10 herds. Dunne 
recovered B. bronchiseptica from the nasal cavity of a pig 
suffering from pneumonia caused by the same agent. 
Ross (1965) and Duncan (1965) reported on an extensive 
study of the microbiology, serology, pathology, and patho­
genesis of atrophic rhinitis caused by experimental inoculation 
of swine with B. bronchiseptica. Using respiratory disease 
free swine as their experimental animal, 1 group of swine were 
inoculated at 3 days of age and a second group of swine were 
inoculated at 4 weeks of age with B. bronchiseptica. The 
virulence of the organism had boen enhanced by passage in 
embryonating chicken eggs. The first group was necropsied in 
subgroups at 1, 2, 3, 5, and 20 weeks postinoculation. The 
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second group was necropsied in subgroups at 1, 2, 3, 4, 6, and 
8 weeks postinoculation. In group 1, 94 percent of the animals 
necropsied between 2 and 5 weeks postinoculation had turbinate 
atrophy and in group 2, 66 percent of the animals necropsied 
between 2 and 8 weeks postinoculation had turbinate atrophy 
(Duncan et , 1966b and Ross et , 1963a). The organism 
was consistently recovered from the nasal cavity at necropsy in 
both groups through 5 and 8 weeks postinoculation respectively. 
Of the 11 pigs which were necropsied from group 1 at 20 weeks 
postinoculation, only 2 pigs were positive for B. bronchiseptica 
in the nasal cavity (Ross, 1965). Seven of these 11 pigs 
exhibited macroscopic lesions of distorted turbinates due to 
atrophy and regeneration (Ross, 1965 and Duncan, 1966b). 
Ross (1965) also conducted plate and tube agglutination 
tests from the sera collected at necropsy of both groups. 
Detectable serum agglutinin, specific for B. bronchiseptica, 
did not occur in group 1 until 20 weeks postinoculation and in 
group 2 until 6 and 8 weeks postinoculation. Duncan (1965) 
and Duncan et al. (1966b) described the microscopic lesions of 
the nasal turbinate occurring in these 2 groups of experimental­
ly infected swine. The primary lesions were hyperplasia and 
metaplasia of the epithelium, fibrosis of the lamina propria, 
neutrophil and mononuclear infiltration of the lamina propria, 
and osseous resorption and replacement fibrosis. The B. 
bronchiseptica organism was demonstrated on the epithelium among 
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the cilia of the turbinates and trachea by fluorescent antibody 
staining technique but the organism did not appear to invade 
the underlying tissue. Duncan and Ramsey (1965) examined the 
swine turbinate epithelium by electron microscopic techniques 
and discovered that the B. bronchiseptica infection caused the 
cilia to be polyhedral in shape due to swelling and the cilia 
to be fewer in number and spaced further apart. Based on these 
pathogenesis studies Duncan et a_l. (1966b) made the following 
statement : 
"The organism must produce or be responsible 
for the elaboration of some substance which 
diffuses into the tissue and elicits the change 
in the osseous core without causing a marked 
inflammatory reaction." 
These workers postulated that endotoxins could be responsible 
for the lesions described. 
Variation in pathogenicity of different strains of B. 
bronchiseptica for pigs has been reported (Ross £t al,, 1967). 
Intranasal inoculation of pigs 3 days of age with 4 swine 
isolates, a rabbit isolate, a cat isolate, and a rat isolate 
caused mild to moderate turbinate atrophy. An isolate of dog 
origin (D-1) caused no turbinate hypoplasia. The organism was 
isolated from the nasal cavities of all experimental swine at 
necropsy but in lower numbers in the pigs inoculated with the 
rat, dog, and rabbit isolates. Serum agglutinin was detected 
in samples collected at necropsy from the pigs inoculated with 
the swine (3 of the 4 strains), rabbit, and rat isolates. 
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The role of P. multocida in rhinitis of swine has recently 
been more clearly elucidated (Harris and Switzer, 196 8). 
Pasteurella multocida, serotype B, has been shown to cause 
rhinitis and turbinate atrophy in Canadian swine (Gwatkin 
et al., 1953). However, P. multocida, serotype D, was reported 
to be the most common serotype to occur in swine (Carter, 1957). 
Harris and Switzer (196 8) reported that experimental infection 
of swine with serotype D was only accomplished after precondi­
tioning the nasal cavity with B. bronchiseptica infection for 
one week. The dual experimental infection of the swine nasal 
cavity by both bacteria enhanced the degree of turbinate atrophy 
as compared to swine affected with B. bronchiseptica alone. 
Since the early I960's B. bronchiseptica has often been 
isolated from the swine nasal cavity. Cross and Claflin (1962) 
isolated the organism from swine in 10 Indiana herds which 
contained pigs affected with atrophic rhinitis. Ross (1963 and 
1965) reported that, based on pigs from 87 herds submitted to 
the Iowa Veterinary Diagnostic Laboratory for various reasons, 
38 percent of the herds were positive for B. bronchiseptica and 
that of the 34 pigs positive for the organism, 29 percent had 
turbinate atrophy. In another survey of nasal mucus samples 
submitted from pigs suspected of having rhinitis, 56 percent of 
32 herds were infected with B. bronchiseptica. In a second 
survey of nasal mucus collected from 28 Iowa swine herds 
suspected of having rhinitis, 68 percent of the herds were 
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infected with the organism (Ross, 1963 and 1965). Ross et al., 
(1963b), and Ross (1965) collected nasal exudate from four 8-
to 10-week-old purebred swine from each of 87 herds in Iowa. 
Fifty-four percent of these herds were infected with B. bronchi-
septica. 
Shortly after these surveys were conducted, it was dis­
covered that addition of sulfonamides (sulfamethazine and 
sulfaethoxypyridazine) to the swine ration at the level of 100 
grams per ton would clear B. bronchiseptica from the nasal 
cavity of swine 3-5 weeks (Switzer, 1963). These sulfonamides 
have been incorporated with growth promoting antibiotics and 
have enjoyed wide popularity as feed additives for swine rations 
(Harris et a]^., 1967). In 1967, the nasal cavities of four 6-
to 8-week-old purebred swine from each of 102 herds in Iowa were 
cultured bacteriologically (Harris et aly, 1969). Results of 
this survey indicated that 25 percent of the herds had B. 
bronchiseptica and the isolates of the organism recovered from 
20 herds (80 percent) were resistant to sulfonamides as deter­
mined by sensitivity disc assay. Sulfonamide resistant strains 
of B. bronchiseptica were isolated repeatedly from swine in a 
herd undergoing therapy with sulfonamides at recommended levels 
(Harris and Switzer, 1968) . Harris et (1969) concluded that 
the high incidence of sulfonamide resistant B. bronchiseptica in 
Iowa swine: 
"...presents an imposing barrier to the control 
of atrophic rhinitis by therapy and emphasizes 
the need for other methods of control." 
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Complete nasal resistance to B. bronchiseptica may bç 
established in swine by either the previous infection by a 
virulent strain (B) and clearance by sulfonamide therapy or 
the previous intranasal exposure to a low-virulence strain 
(D-'l) (Harris and Switzer, 1969) . After clearing the low-
virulence strain infection (4-6 weeks after initial exposure) 
experimental swine are resistant to subsequent challenge to 
virulent strain for at least 95 days. Intranasal challenge 
with virulent B. bronchiseptica, given 16 times during a 53-day 
period, did not cause respiratory infection in resistant swine. 
Resistance of Various Animals to 
Bordetella bronchiseptica and 
Bordetella pertussis 
Ferry (1911) reported the first immunization studies 
utilizing B. bronchiseptica, the organism then believed to be 
the cause of canine distemper. Nine dogs were given a live 
broth culture and 17 dogs were given a killed suspension (1 per­
cent formaldehyde) of B. bronchiseptica subcutaneously. These 
dogs were challenged by natural exposure to canine distemper at 
the same time as 8 unvaccinated control dogs. All of the con­
trols died and all immunized dogs remained clinically normal. 
Serum agglutinins were detected in both infected and vaccinated 
dogs. McGowan (1911) obtained similar protection to natural 
exposure by means of subcutaneous injection of live organisms. 
Formaldehyde inactivated B. bronchiseptica bacterins were 
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reported to protect rabbits and guinea pigs against an 
epizootic of respiratory disease assumed to be caused by the 
organism (Ferry, 1914). Ferry and Hoskins (1920) prevented 
snuffles in rabbits with a bacterin containing B. bronchisep-
tica, Bacterium lepisepticum, and Staphylococcus albus. 
Wickert et (1958) prepared bacterins containing heat killed 
B. bronchiaeptica (60° C for 20 minutes) preserved with 0.05 
percent formaldehyde. The organism had been isolated from 
pneumonic lesions in rats. In intranasally challenged rats, 
1 of 50 vaccinated rats (injected subcutaneously) died while 18 
of 57 unvaccinated rats died. In natural exposure experiments, 
2 of 247 vaccinated rats died while 9 of 247 unvaccinated rats 
died. Serum agglutinins were ditected in both infected and 
vaccinated rats. Phillips (1944) and Ray (1950) reported that 
a bacterin containing B. bronchiseptica prevented pneumonia 
associated with the organism in swine. Daugherty (1941) re­
ported that swine with rhinitis showed a clinical improvement 
when treated with a mixed canine bacterin containing B. bron­
chiseptica. In all of these studies there was no attempt to 
recover B. bronchiseptica from the respiratory secretions of 
vaccinated animals. 
One of the first attempts to study the mechanism of 
respiratory immunity was conducted by Bailey who utilized the 
nasal infection of rabbits (Bailey, 1927). Sera from rabbits 
infected intranasally with B. bronchiseptica contained antibody 
detectable by agglutination but not by complement fixation. 
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Rabbits infected intranasally with a heavy concentration of 
the organism had higher serum agglutinin titers. Phagocytosis 
of B. bronchiseptica by segmented neutrophils occurred in the 
presence of sera from both carrier and non-carrier rabbits. 
The author arrived at the following conclusion: 
"In considering the mechanism of respiratory 
immunity, our results lead us to conclude 
that both local and general resistance play 
important roles in determining whether definite 
infection will result." 
Bull and McKee (1928) reported that pneumococci transiently 
infect the rabbit nasal cavity while B. bronchiseptica occurs 
as a more chronic infection. The pneumococcal carrier state 
ended with the appearance of complement fixing antibody in the 
serum. Rabbits injected subcutaneously with both live and heat 
killed suspensions of pneumococci resisted intranasal exposure 
to the organism. The serum of the vaccinated rabbits contained 
complement fixing antibody. By contrast, rabbits injected sub-
cutaneously with heat killed suspensions of B. bronchiseptica 
produced high titers of complement fixing antibody but did not 
resist intranasal challenge by the same organism. 
Ganaway et al, (1965) prevented guinea pig pneumonia, 
caused by B. bronchiseptica, by the use of a bacterin prepared 
from the organism inactivated with 0.15 percent formaldehyde. 
Two-hundred and eighty-eight guinea pigs were injected once 
intramuscularly with the bacterin mixed with equal parts Freund 
incomplete adjuvant. The vaccinated animals were exposed 
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naturally to B. bronchiseptica and no deaths occurred in them. 
The respiratory secretions from 10 guinea pigs necropsied 7 
months after vaccination did not contain B. bronchiseptica. 
The unvaccinated group containing 29 3 guinea pigs had many 
deaths due to pneumonia,and B. bronchiseptica was recovered 
frequently from the respiratory secretions. Serum agglutinins 
were demonstrated from the vaccinated guinea pigs. 
Several workers have demonstrated the relatedness of B. 
bronchiseptica and B. pertussis by cross immunization. Evans 
and Maitland (19 39) injected guinea pigs subcutaneously with a 
heat killed suspension (56° C for 30 minutes) of B. pertussis 
and challenged them intranasally with a culture of B. bronchi­
septica. Three of 6 unvaccinated control guinea pigs died and 
none of 7 vaccinated guinea pigs died. Lung cultures from all 
control guinea pigs were positive for B. bronchiseptica, while 
the lungs of the vaccinated guinea pigs were negative. Anti­
body was detected in sera from the vaccinated guinea pigs by 
both agglutination and complement fixation tests. Eldering 
(1941, 1942) utilized the mouse to study cross protection of 
Bordetella species. She (Eldering, 1941) injected mice sub-
cutaneously with merthiolate (1:5000) inactivated whole cells 
and lipopolysaccharide fractions (extracted by alcohol and 
trichloracetic acid) of B. bronchiseptica. Vaccinated and un­
vaccinated control mice were then inoculated intraperitoneally 
with live suspensions of either B. bronchiseptica, B. pertussis, 
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or B. parapertussis. Eldering (1942) prepared whole cells and 
lipopolysaccharide fractions of B. pertussis and B. para­
pertussis , and studied their cross protective ability using the 
same methodology (Table 1). Cultural and serological data were 
not reported» 
Cross protective ability of the Bordetella species in mice 
was determined by Kendrick et al. (1953) using intraperitoneal 
immunization with merthiolate (1:5000) inactivated whole cell 
vaccinoG and intracerebral challenge with live cultures. These 
results were similar to those of Eldering (1941, 1942) regarding 
mice vaccinated with either B. bronchiseptica, B. pertussis, or 
B. parapertussis and challenged with B. bronchiseptica. Pro­
tection was also adequate with mice vaccinated with B. pertussis 
or B. bronchiseptica and challenged with homologous culture. 
Mice vaccinated with either B. bronchiseptica or B. para­
pertussis did not resist challenge against B. pertussis. The 
discrepancies in these results may be explained by the variation 
in the method of challenge and the dose of challenge organisms. 
Ross e;t (19 69) reported a detailed study of the mouse 
protective antigens of Bordetella species utilizing the intra­
cerebral challenge test. They found that active immunization 
with heat inactivated whole cells (56° C for 20 minutes) and a 
saline extract of B. bronchiseptica protected against homologous 
challenge but not against challenge by B. pertussis. Whole 
cells and some saline extracts of B. pertussis protected 
against both challenge by B. bronchiseptica and B. pertussis. 
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Table 1. Summary of cross protection studies of the various 
Bordetella species conducted in mice (Eldering, 19 41 
and 19 42) 
Challenge organism 
Vaccine B. bronchiseptica B. pertussis B. parapertussis 
B. bronchiseptica 
Whole cells 7/30' 
Fraction 5/8 3 
Unvaccinated 81/85 
7/25 
7/42 
77/89 
10/15 
18/34 
45/46 
B. pertussis 
Whole cells 
Fraction 
Unvaccinated 
21/55 
N.D.b 
30/30 
11/32 
5/29 
122/138 
1/14 
N.D. 
12/15 
B. parapertussis 
Whole cells 1/30 
Fraction 6/25 
Unvaccinated 24/27 
17/27 
27/31 
25/29 
0/23 
15/42 
54/57 
^Numerator designates number dead; denominator designates 
number of mice in group. 
^Not determined. 
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Whole cells and a saline extract of B. parapertussis protected 
against challenge by B. bronchiseptica but not B. pertussis. 
However, saline extracts of most B. pertussis strains, while 
protecting against homologous challenge, did not protect against 
B. bronchiseptica challenge. This suggested that 2 antigens 
may be responsible for B. pertussis induced protection. The 
antigen responsible for protection against B. bronchiseptica 
that was present in saline extracts of B. bronchiseptica was 
more resistant to heat than the antigen from saline extracts of 
B. pertussis. 
Winsser (1960) attempted active immunization of mice by 
intraperitoneal injection of whole cells of either B. bronchi­
septica or B. pertussis inactivated by merthiolate (1;5000). 
Both types of vaccinated mice were challenged with B. bronchi­
septica intranasally. The B. bronchiseptica vaccinated mice 
were protected against death and the organism was not recovered 
from the lungs at necropsy. The B, pertussis vaccinated mice 
died and B. bronchiseptica was recovered from the lungs at 
necropsy. 
Kendrick et (19 39) first demonstrated protection 
against whooping cough in humans by the use of B. pertussis vac­
cines. Bordetella pertussis was inactivated with merthiolate 
(1:10,000) or phenol (0.5 percent) and administered subcuta-
neously to 1815 children. There ware 2397 unvaccinated control 
children in the experiment. Only clinical evaluations were 
made. There were 52 cases of whooping cough in the vaccinated 
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group and 348 casep of the disease in the unvaccinated group. 
The literature contains numerous subsequent reports concerning 
various vaccine field studies, potency testing of vaccines, 
purification of the protective antigen of the vaccine^ and 
epidemiological studies involving the carrier state of B, 
pertussis infection in humans. Only selected references which 
have relevance to B. bronchiseptica resistance in swine are 
included in the following discussion. 
During the ensuing years since the first report of a suc­
cessful vaccine for the protection of children against whooping 
cough, several laboratories have attempted to standardize their 
vaccines by active or passive immunization of mice followed by 
challenge by the intraperitoneal or intranasal route. These 
attempts met with limited success, Kendrick et (1947) 
investigated the possibility of potency testing of vaccines by 
active immunization of mice followed by challenge by the intra­
cerebral route. This technique was reproducible as conducted 
by several researchers and detected differences in various 
vaccines submitted from 10 laboratories. In 1956, the Medical 
Research Council (of England) published the compilation of a 
series of studies regarding the potency of various vaccines 9s 
compared by field results and intracerebral mouse protection 
tests. The field and laboratory results showed a correlation 
between the potency of vaccines in protecting children, their 
ability to protect mice against intracerebral challenge, and 
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their ability to produce agglutinin in the serum of both mice 
and children (Medical Research Council, 1956). Pillemer et al. 
(1954) attempted to isolate the protective antigen of B. per­
tussis by sonic disintegration of the organism followed by 
adsorption with red cell stromata. Efficiency of separation 
was based on intracerebral mouse protection tests. Evans and 
Perkins (1955) demonstrated that this purified protective anti­
gen possessed a small quantity of agglutinogen and produced a 
poor agglutinin response in mice. Recently, Holt and Spasojevic 
(19 68) reported that growth of various strains of B. pertussis 
on different media would lead to the loss of surface agglutino­
gens. When these agglutinogen deficient preparations were used 
as vaccines, they were found by means of intracerebral mouse 
protection tests to be as protective as parent strains pos­
sessing the normal agglutinogen content. 
Keogh et (1947) reported that whole B. bronchiseptica, 
B. pertussis, and B. parapertussis cells, filtrates, and 
supernatants of broth cultures would cause agglutination of 
human, mouse, and fowl erythrocytes. Keogh and North (194 8) 
demonstrated that human and rabbit antisera possessing high 
titer anti-hemagglutinin,.' would protect mice against death due 
to B. pertussis inoculated intranasally. However, a purified 
hemagglutinin of B. pertussis, prepared by Masry (1952), did 
not prevent death in mice challenged either by the intracerebral 
or intranasal routes. Protection was attempted either by active 
immunization with the hemagglutinin or by passive immunization 
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with anti-hemagglutinin. 
Since it was shown that agglutinin and anti-hemagglu-
tinin were not involved in induction of protection in mice 
against death due to massive B. pertussis challenge, great 
effort has been extended in an attempt to isolate, purify, and 
identify the protective antigen of B. pertussis active in the 
intracerebral mouse protection test. The extraction method 
using red cell stromata (Pillemer e;t , 1954) was difficult 
to reproduce with different strains and loss of activity 
occurred during sonic disruption. Barta (1963) extracted the 
protective antigen from B. pertussis with sodium desoxycholate. 
Munoz (1963) found this procedure difficult to reproduce and 
that the protective antigen extracted by this method contained 
material which sensitized certain strains of mice to histamine. 
Munoz and Hestekin (1963) prepared the protective antigen of 
B. pertussis by saline extraction of fractionated cells. This 
saline extract was purified by starch block electrophoresis but 
the protective antigen and histamine sensitizing factor were 
inseparable and believed to be identical. By contrast, Nagel 
(1967) separated the protective antigen from the histamine 
sensitizing factor of B. pertussis by ultracentrifugation. 
Although the most prevalent method of studying pertussis 
immunization has been the use of the intracerebral mouse pro­
tection test, several workers have utilized the mouse respira­
tory tract as a more natural model for investigating resistance 
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to B. pertussis infection. Cooper (1952) induced resistance 
in mice against intranasal challenge by B. pertussis by the use 
of pertussis vaccine administered intranasally. These intra-
nasally immunized mice were not resistant to intracerebral 
challenge. Cooper also demonstrated that in mice infected with 
sub-lethal doses of B. pertussis by intranasal inoculation, the 
number of organisms in the lungs increased to a maximum on the 
seventh day and declined thereafter. These mice resisted 
intracerebral challenge at 4 weeks but not 6 weeks after the 
initial infection. Andersen (1953) inoculated mice intranasally 
with the sub-lethal doses of B. pertussis and demonstrated the 
organism in the lungs up to 59 days after exposure. When these 
mice were challenged intranasally with sub-lethal doses at 70 
days after exposure, the lungs were clear of the organism 4-8 
days after reinfection. Serum agglutinins were detected 38 
days after the first exposure. 
Standfast (1958) demonstrated that the potency of vaccines 
assayed by intranasal challenge was different from the potency 
assayed by the intracerebral route. He showed that the antigen 
responsible for intracerebral protection was more heat labile 
than the antigen responsible for intranasal protection. Dolby 
and Standfast (1958) found 2 distinct antibodies in rabbit 
antisera against B. pertussis. One antibody passively pro­
tected mice against lethal infection by the intracerebral route 
and the other passively protected mice against lethal infection 
by the intranasal route. Andersen and Bentzon (1958) utilized 
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the number of organisms recovered from the lungs to measure 
protection of vaccinated mice against challenge with sub-lethal 
doses of B. pertussis administered intranasally and observed a 
correlation with vaccines assayed by lethal intracerebral chal­
lenge. Dolby et (1961) inoculated untreated and actively 
immunized mice intranasally with lethal doses of B. pertussis. 
By the 25th day of infection, all control mice had died and all 
lungs were positive for the organism. Of the vaccinated mice, 
5 of 60 died during the 28 day observation period. One vac­
cinated mouse was necropsied every 5 days and the number of 
sterile lungs was 60 percent by the end of the experiment. 
Dolby and Dolby (1969) prepared rabbit antisera against 
B. pertussis and fractionated the sera into 7s and 19s globulin 
components. These components were incubated with lethal doses 
of the organism before intracerebral challenge and with sub­
lethal doses of the organism before intranasal challenge in 
mice. Evaluation of protection was based on brain and lung 
counts of B. pertussis. The 7s globulin was 100 times more 
effective than 19s both in the bactericidal reaction vitro 
and in protection against intracerebral challenge. By contrast, 
the minimal weights of 7s and 19s globulins required to 
neutralize hemagglutinin and to protect against intranasal 
challenge were similar. These workers postulated that the 
antibody responsible for protection in the intracerebral mouse 
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protection test was bactericidal and differed from the antibody 
responsible for protection against intranasal infection. 
Respiratory Tract Resistance to Infectious Agents 
Resistance to infectious agents by the respiratory tract 
of a mammalian host has been divided into 2 broad categories; 
these are natural and acquired resistance. 
Natural resistance 
The respiratory tract has the capacity for the elimination 
of infectious agent laden particulate matter. Due to the 
tortuous design of the nasal cavity, most of the air stream 
during inspiration is concentrated over a small portion of the 
nasal surface. While during expiration, the air stream is dif­
fusely spread through the entire nasal passage. Malformations 
such as septal deviations and nasal polyps in humans may con­
centrate air flow onto an even smaller area which may have a 
drying effect on the mucosa (Proctor, 1966). 
The mucous membrane of the upper respiratory tract of 
mammals consists of ciliated pseudostratified columnar 
epithelium beginning at the posterior edge of the anterior end 
of the nasal turbinates and extending into the nasopharynx 
(Copenhaver and Johnson, 195 8). The nasopharynx contains 
transitional and stratified squamous epithelium. The trachea 
and bronchi contain ciliated pseudostratified columnar 
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epithelium which changes to a nonciliated columnar cell type 
in the terminal bronchioles. Goblet cells and mucosal glands 
supply mucus which covers the ciliated portions of the res­
piratory tract. 
The mucus covering the cilia is kept continually in 
motion by the cilia, traveling posteriorly in the nasal cavity 
and anteriorly in the tracheobronchial tree to the unciliated 
portions of the hypopharynx where the mucus is swallowed 
(Proctor, 1966) . Quinlan et (1969) demonstrated that small 
radioactively tagged particles travel at a rate of 7 mm per 
minute in the nasal mucociliary flow of normal human subjects. 
Wells and Wells (1936) reported that microorganisms are 
usually contained in the inspired air in nuclei that are 2 to 
3 microns in diameter. Wells (1955) found that when tubercle 
bacilli were contained in droplet nuclei less than 3 microns 
in diameter, a more severe pneumonia resulted in rabbits than 
if the droplet nuclei were 10-12 microns in size. 
Apparently, particulate matter in excess of 10 microns in 
diameter is readily removed by the mucociliary system due to 
impingement of these particles in the mucus. Many particles 
less than 10 microns in size may penetrate the lower respiratory 
tract to the aveoli of the lung. These particles which pene­
trate beyond the mucociliary apparatus have been reported to be 
engulfed and destroyed by the alveolar macrophages. These 
macrophages may be removed by the mucociliary apparatus or by 
the lymphatic system (Wright, 1961). When the alveolar macro-
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phages or the mucociliary apparatus fails to remove an in­
fectious agent, inflammation of the respiratory tract may 
occur leading to the influx of polymorphonuclear (PMN) leuco­
cytes (Green, 1968). The PMN leucocytes are also capable of 
engulfing and destroying microorganisms as a secondary line of 
defense in the respiratory tract (Weiser et al., 1969). 
Weiser et a]^. (1969) states that the PMN leucocytes have 
a relatively short duration of life and the disintegrating PMN 
cells supply hydrolytic enzymes for the destruction of microbial 
agents. Zeya and Spitznagel (1966) reported that the cationic 
fraction of lysosomes extracted from PMN cells contained 
enzymes (including lysozyme) which were bactericidal for strep­
tococci and staphylococci. Hirsch (1956) had previously 
reported that rabbit PMN leucocytes contained a heat stable 
protein called phagocytin which was bactericidal for certain 
Gram negative bacteria. Dajani and Ayoub (1969) demonstrated 
that a substance from PMN cells would lyse Mycoplasma 
pneumoniae. 
Two types of mucus (sulphomucin and sialomucin) have been 
reported to be produced in rat respiratory tract secretions 
(Lamb and Reid, 1968). Viral agents (Luria and Darnell, 1967) 
and Mycoplasma pneumoniae (Sobeslavsky et , 1968) have been 
reported to attach to neuraminic acid receptor sites of tracheal 
epithelial cells. 
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Acquired resistance 
It is convenient to divide acquired resistance of the 
respiratory tract into humoral and cellular factors (Austen and 
Cohn, 19 63). 
Humoral factors Specific antibody and interferon have 
been shown to exist in the respiratory secretions of man. 
Bellanti et al. (1965) reported that virus neutralizing 
activity of human serum was associated with immunoglobulin (Ig) 
G while in nasal secretions the antibody activity was associated 
with IgA. These workers also reported that IgA was the pre­
dominant immunoglobulin in nasal secretions. Recovery from 
respiratory infections caused by parainfluenza Type 1 virus has 
been correlated with the presence of neutralizing antibodies 
in nasal secretions rather than in the serum (Smith et , 
1966). 
Resistance to A2 influenza virus in humans has been cor­
related with IgA present in nasal secretions. The IgA was 
reported to have virus neutralizing and hemagglutination-
inhibiting activity (Alford et al., 1967). Bellanti e_t al. 
(1967) demonstrated that either injection of an attenuated 
tularemia vaccine subcutaneously or experimental intranasal 
infection with Francisella tularensis in humans would induce 
indirect hemagglutinating antibodies in both the nasal secre­
tions and serum. Resistance was not induced with the vaccine. 
The serum antibody activity was associated with IgM while the 
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nasal secretion antibody activity was associated with IgA. No 
mechanism has been described which would explain the mode of 
action of IgA in respiratory tract resistance to bacterial 
infections. 
Butler et (1967) has shown that 2 types of IgA are 
present in nasal secretions; these occur as a 7s and an lis 
molecule. The 7s IgA molecule has been shown to be present in 
serum and to originate from serum when present in nasal secre­
tions. The lis IgA molecule, however, has been demonstrated 
to be synthesized ^  novo in the tissues of the upper respira­
tory tract. Tomasi (1969) reported that the lis IgA molecule, 
with a molecular weight of 380,000, consists of a dimer of 7s 
IgA plus a secretory piece (SP) with a molecular"weight of 
58,000. The SP has been shown to originate from the respiratory 
tract epithelium. 
Isaacs (196 3) reported that production of interferon in 
the lungs of mice infected with sublethal doses of influenza 
correlates with the decline of disease symptoms. He also 
reported that aging mice develop an increased ability to 
eliminate this virus from their lungs which is accompanied by 
an increased production of interferon. 
Cellular factors weiser et al. (19 69) did not consider 
PMN leucocytes to be a part of cellular immunity or resistance. 
These cells do not undergo specific immunological activation 
upon the 2nd encounter with an infectious agent. The lung 
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alveolar macrophage represents the principal effector cell 
type in acquired cellular resistance to respiratory disease. 
Dannenberg (1968) has demonstrated that delayed cellular 
hypersensitivity in tuberculosis is a specific immunological 
process in which most macrophages and lymphocytes of the host 
become sensitive to tuberculin. This hypersensitivity is both 
local and systemic in nature. In cellular immunity or resis­
tance, the activated macrophage is able to destroy tubercle 
bacilli, in its cytoplasm. Cellular immunity in contrast to 
delayed hypersensitivity is more local in nature and is not a 
specific immunological process. This lack of specificity is 
demonstrated by the fact that macrophages with acquired cel­
lular resistance to tuberculosis have an increased ability to 
destroy other infectious agents such as Brucella melitensis 
(Elberg et al., 1957), Salmonella spp. and Escherichia coli 
(Jenkin and Benacerraf , 1960). 
Cellular resistance to other respiratory pathogens has 
been reported; these are Francisella tularensis in the rabbit 
(Nutter and Myrvik, 1966) and B. pertussis in the mouse (Gray 
and Cheers, 1967). 
37 
MATERIALS AND METHODS 
Source of Bordetella bronchiseptica and 
Bordetella pertussis Isolates 
Two isolates of B. bronchiseptica of swine origin were 
used; (1) virulent strain B was isolated from a pig with 
turbinate hypoplasia and had been used to produce turbinate 
hypoplasia in experimental swine (Ross et , 1963a and Harris 
and Switzer, 1968)^, and (2) strain IVDL 374 was isolated from 
a pig with turbinate hypoplasia which was submitted to the Iowa 
2 
Veterinary Medical Diagnostic Laboratory, Ames, Iowa . An 
isolate of B. bronchiseptica designated low-virulence strain 
2 
D-1 was isolated from a puppy infected with canine distemper . 
The low-virulence D-1 strain isolate had been shown in a pre­
vious study to be incapable of causing turbinate hypoplasia in 
swine (Ross ^  , 1967). 
An isolate of B. pertussis f strain 3779 A, was obtained 
from a commercial biological company where it was used for the 
preparation of a vaccine for the prevention of whooping cough 
in humans^. 
^Dr. W. P. Switzer, Veterinary Medical Research Institute, 
Iowa State University, recovered this isolate. 
2 Dr. R. F. Ross, Veterinary Medical Research Institute, 
Iowa State University, recovered these isolates. 
^Sli Lilly and Company, Indianapolis, Indiana. 
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Source of Pasteurella multocida and 
Haemophilus spp. Isolates 
Pasteurella multocida, serotype D, was isolated from a 
pig with turbinate hypoplasia submitted to the Veterinary 
Medical Research Institute, Ames, Iowa. This isolate had been 
used in combination with B. bronchiseptica, strain B, to pro­
duce turbinate hypoplasia in swine (Harris and Switzer, 1968). 
Haemophilus spp. was isolated from a pig submitted to the 
Veterinary Medical Research Institute, Ames, Iowa. 
Culture Media 
Bordetella bronchiseptica was isolated by inoculating 
specimens on modified MacConkey's agar^ containing 1 percent 
dextrose (Ross, 1963). Pasteurella multocida and Haemophilus 
spp. were isolated on horse blood agar composed of 5 percent 
difibrinated horse blood in tryptose blood agar base medium^. 
Bordetella bronchiseptica and P. multocida were propagated 
in tryptose phosphate broth (TPB)^. Media for the biochemical 
identification of these organisms were commercial dehydrated 
media^. Bordetella pertussis was propagated on horse blood 
agar prepared by the addition of 16 percent horse blood to 
Bordet Gengou agar base^. Haemophilus spp. was propagated on 
mycoplasma medium containing fresh beef heart infusion broth, 
0.2 percent hemoglobin, 0.5 percent swine gastric mucin, 20 
^Difco Laboratories, Incorporated, Detroit, Michigan. 
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percent turkey serum, and 1.5 percent Noble agar^ (Ross and 
Switzer, 1963). 
Bordetella bronchiseptica Inocula 
Cultures of B. bronchiseptica used in transmission experi­
ments were stored lyophilized in low passage. Inocula of 
strain B and strain 374 for intranasal and intratracheal inocu­
lations were prepared by injecting 0.1 ml of 24-hour broth 
cultures into the yolk sac of 6- to 8-day-old embryonating 
chicken eggs. The embryos were incubated at 31°C and candled 
daily. Embryos dying after 24 hours incubation were incubated 
an additional 24 hours. Yolk sac fluids were harvested, checked 
for purity on 5 percent horse blood agar, and stored frozen at 
-20°C. 
Inocula of D-1 strain usually consisted of 24 hour culture 
grown in TPB varying between 7 to 12 passages. When D-1 strain 
was grown in embryonating chicken eggs, it had been passaged 
less than 6 times in TPB. B strain inocula refers to yolk-sac 
fluids, and D-1 strain inocula refers to broth culture unless 
stated otherwise in the results section. 
The egg fluid inocula containing B. bronchiseptica strain 
7 9 B had 5.0 X 10 to 1.0 x 10 colony-forming units per ml. The 
egg fluid inocula containing B. bronchiseptica strain IVDL 374 
^Difco Laboratories, Incorporated, Detroit, Michigan. 
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had approximately 2.0 x 10^ colony-forming units per ml of the 
organism. Passage of B. bronchiseptica through embryonating 
chicken eggs resulted in an increased hemolytic activity on 
horse blood agar. 
The B. bronchiseptica D-1 strain inocula used in experiment 
X was previously passaged for 21 times on either modified 
MacConkey's agar or TPB. Inoculum for each passage was the 
smallest colony with the largest central portion observable on 
the plate. After 21 passages, the organism appeared on modified 
MacConkey's agar as a small colony measuring approximately 2 mm 
in diameter containing a large central elevation. This was 
about one-half to two-thirds normal size although the central 
area was larger than normal. Passage 22 was grown in TPB and 
was used as inoculum. 
Respiratory Tract Inoculations 
Swine were inoculated intranasally by inserting the tip of 
a 5 ml syringe (without needle) into the naris. Inoculum 
(0.5 ml) was injected into each side of the nasal cavity. For 
intratracheal inoculation, swine were held in dorsal recumbency 
with their necks extended. The posterior border of the larynx 
was palpated and fixed in position with the thumb and fore­
finger. An area over the trachea was disinfected with 70 per­
cent alcohol and a 20-gauge needle attached to an empty 5-ml 
syringe was then inserted into the trachea. After the needle 
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had entered the trachea (tracheal air could be easily aspirated), 
a 5-ml syringe containing 0.5 ml of inoculum was attached to 
the needle, and the contents were injected. 
Identification of Bordetella bronchiseptica, 
Pasteurella multocida, and Haemophilus spp. 
Bordetella bronchiseptica appeared on modified MacConkey's 
agar as grayish tan colonies after 48 hours of incubation at 
37° C. Further identification was based on lack of acid pro­
duction in dextrose and lactose, hydrolysis of urea within 24 
hours, utilization of citrate and alkalization of litmus milk. 
Pasteurella multocida appeared as grayish white mucoid 
colonies on 5 percent horse blood agar after 24 hours of incu­
bation at 37° C. Identification was based on production of 
acid but not gas from the dextrose, production of indole, and 
failure to produce acid from lactose. 
Haemophilus spp. were identified as minute, flattened 
colonies of Gram negative organisms satelliting along a 
Micrococcus sp. streak growth on 5 percent horse blood agar 
after 24 hours of incubation at 37° C. 
Preparation of Buffered Solutions 
Phosphate buffered saline (PBS) 
The PBS was composed of the following: 
NagHPO^ (0.1 M) 85.7 ml 
KH2PO4 (0.1 M) 14.3 ml 
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Saline (0.85 percent NaCl) 900.0 ml 
The above solution was pH 7.4. 
Veronal buffered diluent (VBD) 
Stock solution was composed of the following: 
NaCl 83.00 gm 
Na-5,5-diethyl barbiturate 10.19 gm 
Distilled HgO 1867.23 ml 
HCl (1 N) 34.58 ml 
Solution containing 
MgClg (1 M) and CaClg (0.3 M) 5.00 ml 
The VBD was composed of the following; 
Stock solution 100.00 ml 
Distilled H^O 400.00 ml 
Gelatin (0.25 percent) 16.00 ml 
The VBD was pH 7.4 and stored at 4-8° C. It was used 
within 24 hours of preparation. 
Preparation of Vaccines 
Sonicate-vaccine 
Five ml of a 24-hour broth culture of 6th passage B. 
bronchiseptica strain D-1 was inoculated onto tryptose blood 
agar (without blood) in Roux flasks and incubated at 37° C for 
48 hours without inversion of the flasks. The growth was har­
vested in 20 ml of distilled water per flask and frozen at 
-20° C. 
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Glass beads were used to loosen the growth from the agar. 
This material was thawed and centrifuged at 4® C for 30 minutes 
at 4000 xg. The supernatant was removed and an equal volume of 
PBS was added. The organisms were re-suspended and 20 ml of 
the suspension was placed in a Rosett Cooling Cell^, Model 24, 
which was contained in a crushed-ice and salt water bath 
maintained at a temperature of 2-G* C. This suspension was 
sonicated for 6-3 minute intervals. Sonication was stopped 
every 3 minutes to allow a 2 minute cooling of the suspension. 
The sonication was performed with a 12 mm diameter Bronwill 
2 Biosonik II ultrasonic probe inserted approximately 4 mm into 
the suspension. The first sonication interval was initiated at 
60 percent of full power. Each succeeding interval was in­
creased until 95 to 100 percent of full power was attained on 
the final 2-3 minute intervals. Severe foaming of the suspen­
sion occurred if 100 percent power was attempted during the 
initial sonication intervals. 
Sonicated material was sterilized by passage through a 
3 0.45 micron APD cellulose filter , and the filtrate was frozen 
at -20° C. On the day of use the filtrate was thawed and 
emulsified with equal parts Freund incomplete adjuvant by 
^Heat Systems Company, Melville, New York. 
2 
Bronwill Scientific, Rochester, New York. 
^Millipore Filter Corporation, Bedford, Massachusetts. 
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repeated passage through a 20-gauge needle attached to a lO-ml 
syringe. The mixture (sonicate-vaccine) was injected sub-
cutaneously in the axillary space of young experimental swine 
in 2 ml amounts in active immunization studies. Sonicate-
vaccine was injected subcutaneously in the fold of the flank 
in pregnant sows in 3 ml amounts for passive immunization 
studies. 
Before sonication, the suspension in PBS contained approxi­
mately 2.1 X 10^^ colony-forming units per ml of B. bronchi-
septica or a reading of 12 to 13 nephelos units at 1:1000 
dilution of the suspension on a Nepho-Colorimeter^, adjusted 
to a standard of 20. After the 6th sonication interval, the 
0 
suspension contained approximately 1.9 x 10 colony-forming 
units per ml or a reading of 4 nephelos units at a 1:1000 dilu­
tion adjusted to a standard of 20. 
Pertussis-vaccine 
2 Pertussis Vaccine Fluid, U.S.P. was emulsified with equal 
parts of Freund incomplete adjuvant by repeated passage through 
a 20-gauge needle attached to a 10-ml syringe. The mixture 
(pertussis-vaccine) was injected subcutaneously in the axillary 
space of experimental swine in 2 ml amounts of active immuniza­
tion studies. 
1 Coleman instruments Corporation, Maywood, Illinois. 
2 Eli Lilly and Company, Indianapolis, Indiana. 
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Whole cell-vaccines 
Five ml of a 24-hour broth culture of 7tp. passage B. 
bronchiseptica strain B was inoculated onto tryptose blood agar 
(without blood) in Roux flasks and ipcubated at 37° C for 48 
hours without inversion of the flasks. The growth was har­
vested with the aid of glass beads in 50 ml of 0,85 percent 
NaCl solution per flask. Formalin was added to the suspension 
to obtain a final concentration of 1:1000, This suspension was 
kept at ambient room temperature until it was inactivated and 
then stored at 4-8° C. Inactivation occurred within 4 8 hours. 
This material (whole cell-vaccine, B strain) was injected 
intramuscularly into the hams of swine 3 ml amounts. 
Five ml of a 24-hour broth culture of 7^^ passage B. 
bronchiseptica strain D-1 was inoculated onto Bordet Gengou 
agar (without blood) in Roux flasks, and the flasks allowed to 
stand without inversion for 30 minutes at room temperature. 
The flasks were inverted and incubated for 48 hours at 37° C. 
Before harvesting, the excess inoculum in the flasks were poured 
off. Ten ml of 0.85 percent NaCl containing 1:1000 formalin 
was added to each flask and allowed to stand at room temperature 
for 1 hour. Glass beads were added and the suspension har­
vested. Five ml of 0.85 percent NaCl containing 1:1000 
formalin was added to each flask for a pecond harvesting. The 
harvest from each flask was pooled and refrigerated at 4^8° C. 
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The organisms were inactivated after 10 days of refrigeration 
and were used for injection into swine 13 and 21 days after 
harvest. A 1:100 dilution of the material gave a reading of 71 
nephelos units, adjusted to a standard of 20, on a Nepho-colori-
meter. The concentrated material was mixed with equal parts 
Freund incomplete adjuvant by repeated passage through a 2 0-
gauge needle attached to a 10-ml syringe. This mixture (whole 
cell-vaccine, D-1 strain) was injected subcutaneously into the 
axillary space of swine in 2 ml amounts. 
Source and Care of Experimental Swine 
Swine were obtained from the respiratory-disease-free herd 
maintained at the Veterinary Medical Research Institute, Ames, 
Iowa. Original stock was surgically derived 19 years ago, and 
strict health management practices have been conducted since 
that time. The ration fed both the herd and the experimental 
pigs did not contain antibiotics, sulfonamides, or arsenicals. 
The feed contained a calcium:phosphorus ratio satisfying recom­
mendations of the National Research Council (1964). 
Three age groups of pigs were used: (1) Newborn pigs were 
farrowed naturally in isolation units. Each pig was injected 
intramuscularly with 1 ml of Armidexan^ (iron dextran solution) 
at 3 days of age. The pigs had access to a creep ration (18 
^Bradley Products Company, Bradley, Illinois. 
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percent protein) beginning at 1 week of age and were weaned at 
approximately 4 weeks of age. A grower ration (16 percent 
protein) was fed from the 5^^ week of age, (2) Two- to 3- week-
old pigs were weaned in the supply herd and were placed in 
isolation units. The pigs were initially fed the 18 percent 
protein creep ration and were shifted to the 16 percent protein 
grower ration at 4 to 5 weeks of age, A preweaning creep 
ration was prepared by the addition of 10 percent ferrous 
sulfate to the 18 percent protein creep ration. Early weaning 
was facilitated by feeding this iron-rich creep to the pigs 
from the 2nd day of life until 1 week after weaning. The pigs 
were then fed the regular 18 percent protein creep ration. 
Additional supplemental iron was not supplied, (3) Four-week-
old or older pigs were weaned in the supply herd and fed the 
grower ration while on experiment. 
Animal Experiments 
Principal and infected control swine were housed in iso­
lation during the course of the experiments. Unexposed swine 
were either housed in isolation units or remained in the supply 
herd until necropsy. 
The procedure followed in the animal experiments was vari­
able with regard to age of experimental swine, time of intra­
nasal inoculations, nasal secretion and blood collection, and 
necropsy. Therefore, these parameters of methodology are 
48 
included in the results section to facilitate interpretation 
of the experiments. 
All serum antibody titers against B, bronchiseptica and 
B. pertussis which are presented in the results section were 
determined by the particulate antigen settling test upless 
stated otherwise. 
Collection of Specimens 
Nasal secretions were collected ^  vivo on cotton-tipped 
wooden applicator sticks (swabs) by inserting the swab approxi­
mately three-fourths of the length of the nasal cavity and 
gently twisting the swab as described by Ross et al. (1963b). 
The nares were cleaned with cotton soaked with 70 percent 
alcohol prior to insertion of the swab. Samples of nasal 
secretions for bacterial culture were collected at necropsy by 
sectioning the head longitudinally and carefully removing the 
median septum. A sterile swab was then rubbed on the posterior 
one-half of the ventral turbinate. 
Tracheal secretions and lung were aseptically collected at 
necropsy. Lung tissue was minced with sterile scissors and 
ground with TPB in a TenBroeck tissue grinder, 
Nasal washings were collected by inserting a rubber female 
catheter into the nasal cavity of a pig with the snout held 
downward at a 45° angle, A syringe was attached to the catheter, 
and a 5 ml quantity of PBS was flushed into the nasal cavity 
49 
during expiration. Washings which dripped out of the nares 
around the catheter were collected in a disposable plastic 
drink cup. The nares were cleaned with cotton soaked with 70 
percent alcohol prior to insertion of the catheter (Figure 1). 
Nasal washings were checked for the presence of occult 
blood using Hemastix^, homogenized by constant stirring at 4-
8° C for 4 hours, centrifuged at 4" C for 30 minutes at 4000 xg. 
2 The supernatant was concentrated by the addition of Lyphogel 
and maintained at 4-8° C overnight. The concentrated nasal 
washings were frozen at -20° C, 
Swine blood samples were collected from the anterior vena 
cava. 
Histological Procedures 
Portions of the ventral turbinates, trachea, and lungs 
were fixed for a minimum of 48 hours in 10 percent buffered 
formalin. Cross sections of the turbinate, in the area of 
maximal scroll development, were decalcified by 1 of the fol­
lowing methods: (1) The tissue was placed in Decal^ solution 
for 48 hours at room temperature and then washed overnight in 
tap water before embedding. (2) The tissue was placed in a 
^Ames Company, Incorporated, Elkhart, Indiana. 
2 Gelraan Instrument Company, Ann Arbor, Michigan. 
^Scientific Products, Evanston, Illinois, 
Figure 1. Nose of a pig was held downward at an approximate 
45° angle for collection of nasal washings. A 
female catheter was inserted into the nasal 
cavity and 5 ml of sterile PBS was dispensed 
slowly into each naris. The nasal washings were 
collected in a disposable drink cup 
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solution of 3 percent disodium ethylenediamine tetraacetate^ 
(EDTA) which was prepared in PBS. The tissues remained in the 
EDTA for a minimum of 10 days and were then placed in 70 per­
cent ethyl alcohol until the embedding process. 
2 The tissues were embedded in Paraplast tissue embedding 
medium, sectioned at 6 microns and mounted on glass slides with 
an albumin fixative. Staining was done with methyl green-
pyronine as described by Pearse (1960) or with Harris' hema­
toxylin and counterstained with eosin Y as described in the 
U.S. Armed Forces Institute of Pathology (1960) Manual of 
Histologic and Special Staining Techniques. Decalcification 
with EDTA solution was required to obtain characteristic 
staining by methyl green-pyronine. 
Antigens 
Bordetella bronchiseptica broth antigens 
D-1 and B strain (8th passage) were grown in TPB for 16 
hours at 37° C and then a 1 ml aliquot was inoculated into 550 
ml of TPB in 1000 ml Erlenmeyer flasks. These cultures were 
incubated 20-24 hours at 37° C. For live broth antigens, the 
growth was harvested by centrifugation at 5-10° C at 15,000 xg 
for 1 hour. The sediment was resuspended in 0.85 percent NaCl 
•^Cainbridge Chemical Products, Incorporated, Detroit, 
Michigan, 
2 Brunswick Laboratories, St. Louis, Missouri. 
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and stored at 4-8® C. For inactivated broth antigens, formalin 
was added to the flasks at a 1:1000 concentration and incuba­
tion at 37° C was continued for another 20-24 hours. Cultures 
on blood agar revealed that the organisms were inactivated 
after this treatment. Cells were harvested by centrifugation 
at 5-10° C at 15,000 xg for 1 hour, resuspended in 0.85 percent 
NaCl containing 1:100 0 formalin and stored at 4-8° C. 
Bordetella bronchiseptica agar antigens 
D-1 and B strain (8th passage) were grown in broth for 24 
hours at 37° C and then 5 ml aliquots were inoculated into Roux 
flasks containing Bordet Gengou agar (without blood). The 
flasks were incubated for 24 hours at 37° C in an inverted 
position. For live agar antigens, a 0.85 percent NaCl with 
glass beads was used to suspend the growth. This suspension 
was stored at 4-8° C. For inactivated agar antigens, glass 
beads in 0.85 percent NaCl containing 1:1000 formalin were used 
to suspend the growth. This suspension was incubated at 37° C 
for 24 hours, and then stored at 4-8° C. The organisms were 
inactivated after 24 hours incubation at 37° C, 
Bordetella pertussis antigen 
Strain 3779A was grown on 16 percent horse blood Bordet 
Gengou agar for 48 hours at 37° C. The growth was harvested 
with 0.85 percent NaCl with glass beads and stored at 4-8° c. 
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Salmonella spp. antigens 
Salmonella binza and S. Virginia^ were grown in broth at 
37° C for 18 to 20 hours and then 5 .ml aliguots were trans­
ferred to Roux flasks containing tryptose agar (without blood). 
The flasks were incubated at 37" C for 20-24 hours without 
inversion. For H antigens, the growth was harvested with 0.85 
percent NaCl containing 1:200 formalin. The suspension was 
incubated overnight at room temperature for inactivation of the 
organisms and then stored at 4-8° C. For 0 antigens, growth in 
flasks was harvested with 0.85 percent NaCl solution. Three 
volumes of 95 percent ethyl alcohol were added; the suspension 
was incubated at 37° C for 2 hours and then centrifuged for 30 
minutes at 4000 xg at 4-8° C. The sediment was resuspended in 
0.85 percent NaCl containing 0.3 percent phenol and stored at 
4-8° C. 
Antisera 
Swine antisera 
Sera used in the various serologic tests utilizing B. 
bronchiseptica antigens were procured from the animal experi­
ments involving swine infected intranasally with live organism 
or injected with a vaccine containing the organism. Sera 
^Obtained from Dr. M. L. Kaeberle, Department of Veterinary 
Microbiology and Preventive Medicine, Iowa State University. 
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containing antibody against Salmonella spp. O and H antigens 
was produced by injecting the appropriate antigen into 4-month-
old swine. The antigen, in concentrated form, was mixed with 
equal parts Freund incomplete adjuvant and. injected subcutane-
ously into the axillary space. Three ml amounts of antigen 
were injected 2 times at 2 week intervals. Blood was collected 
approximately 2 weeks after the last injection. 
Rabbit antisera 
Sera containing antibody to B. bronchiseptica and Salmonella 
spp.^ were produced by intravenous injections of various in­
activated suspensions of the organisms adjusted to a tube 3 
2 McFarland nephelometer . The following injection schedule was 
followed: day 1, 0.5 ml; day 4, 1.0 ml; day 8, 2.0 ml; day 12, 
3.0 ml; and day 16, 3.Ù ml. The rabbits were anesthetized with 
barbiturates and bled by heart puncture on day 21. The 
Salmonella spp. O and H antigens and the B. bronchiseptica in­
activated agar antigens were used for production of the anti-
sera. 
Identification of antisera sample numbers 
The source of swine and rabbit sera which were used in 
various serologic tests are listed in Tables 2 and 3. The 
^Salmonella spp. antisera produced and supplied by the stu­
dents participating in Veterinary Microbiology and Preventive 
Medicine, Serology 520, fall quarter, 1969. 
2 Nephelometer prepared according to procedure in Kolmer and 
Boerner (1931). 
Table 2. Source of serum samples from swine 
No. of 
Sample Experiment Day of donor Exposure^ and/or vaccination 
no. no. experiment swine Experience of donor swine 
1 XVI 57 4 whole cell-vaccine (B strairD - exposed to 
B strain 
142 XIII 105 1 sonicate-vaccine - exposed to B strain 
383a VIII 43 3 D-1 strain cleared - unexposed to B 
strain 
422 XIV 3 12 unexposed control - 3 days old 
424a XVII 40 4 whole cell-vaccine (D-1 strain) -
unexposed to B strain 
46 0a XIV 21 4 sonicate-vaccine - unexposed to B strain 
466a XIV 21 4 pertussis-vaccine - unexposed to B strain 
530 VIII 106 2 D-1 strain cleared - exposed to B strain 
543 XIII 96 4 pertussis-vaccine - exposed to B strain 
544 XIII 96 2 sonicate-vaccine - exposed to B strain 
545 XIII 96 3 unvaccinated - exposed to B strain 
^Intranasal inoculation with B. bronchiseptica (virulent B strain or low-
virulence D-1 strain). 
no. 
572 
573 
574 
575 
576 
614 
615 
685 
686 
691 
693 
694 
(Continued) 
Experiment 
no. 
Day of 
experiment 
No. of 
donor 
swine 
Exposure and/or vaccination 
Experience of donor swine 
XVII 
VIII 
XIV 
XIV 
XIV 
100 
131 
176 
176 
176 
2 unexposed control - 6-8 weeks old 
1 pre-injection bleed for no. 614 
1 pre-injection bleed for no. 615 
4 whole cell-vaccine (D-1 strain) -
exposed to B strain 
4 D--1 strain cleared - exposed to B strain 
1 injected S. binza H antigen 
1 injected £. binza 0 antigen 
2 pertussis-vaccine - exposed to B strain 
2 sonicate-vaccine - exposed to B strain 
4 unvaccinated - exposed to B strain 
2 unexposed control - 6-8 weeks old 
2 unexposed control - 6-8 weeks old 
U1 
cn 
tr 
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Table 3. Source of individual serum samples from rabbits 
Sample 
no. Route of inoculation 
Antigen preparation 
injected 
33 
34 
37 
38 
NRS 
591 
592 
633 
634 
Intravenous 
Intravenous 
Intravenous 
Intravenous 
Normal rabbit serum^ 
Pre-injection for sample 633 None 
Pre-injection for sample 6 34 None 
Subcutaneous 
Subcutaneous 
S. Virginia H antigen 
S^. Virginia 0 antigen 
£. binza H antigen 
S. binza 0 antigen 
None 
B. bronch.iseptica CD-I 
strain) inactivated agar 
antigen 
B. bronchiseptica (B 
strain) inactivated agar 
antigen 
^No history of exposure to Salnonella £P£-
source of nasal washings collected from swine is presented in 
Table 4, 
Serologic Tests 
Particulate antigen settling test (PAST) 
The test was performed iri plastic trays^ with U-shaped 
wells. Diluent for antisera dilutions with B. bronchiseptica 
^Limbro Chemical Company, New Haven, Connecticut. 
Table 4. Source of pooled nasal wash samples from swine 
No. of Exposure and/or 
Sample Experi- Day of donor Hemo- ^ Concen-^ vaccination experience 
no. ment experiment swine globin tration of donor swine 
308 V 56 8 - 5X D-1 strain cleared-
unexposed to B strain 
309 VII 62 8 - 5X D-1 strain cleared-
unexpossd to B strain 
310 VII 74 8 - lOX D-1 strain cleared-
unexposed to B strain 
379 XIII 95 3 + 2X exposed to B strain 
380 XIII 96 4 + 2X pertussis-vaccine -
exposed to B strain 
381 XIII 96 2 + 2X sonicate-vaccine -
exposed to B strain 
435 VIII 6 7 2 — 2X exposed to B strain 
436 VIII 67 4 — 3X D-1 strain cleared -
exposed to B strain 
437 VIII 68 2 — 3X exposed to B strain 
438 VIII 68 4 + 3X D-1 strain cleared -
exposed to B strain 
442 XIV 13 8 - 4X sonicate-vaccine -
unexposed to B strain 
^Determined by an occult blood test. 
^Indicates the reduction in volume due to concentration. 
^Intranasal inoculation with B. bronchiseptica either virulent B strain or low-
virulence D-1 strain. 
443 
456 
457 
472 
473 
474 
475 
489 
493 
499 
500 
533 
534 
652 
653 
(Continued) 
Experi- Day of 
ment experiment 
No. of 
donor Hemo- ^ Concen-^ 
swine globin tration 
Exposure and/or 
vaccination experience 
of donor swine 
XIV 13 4 - 3X pertussis-vaccine -
unexposed to B strain 
VIII 74 2 — 2X exposed to B strain 
VIII 74 4 — 3X D-1 strain cleared -
exposed to B strain 
XIV 21 8 + GX sonicate-vaccine -
unexposed to B strain 
XIV 21 4 - lOX pertussis-vaccine -
unexposed to B strain 
VIII 78 2 — 4X exposed to B strain 
VIII 81 4 + 6X D-1 strain cleared -
exposed to B strain 
VIII 81 4 - 5X D-1 strain cleared -
exposed to B strain 
VIII 83 4 - 3X D-1 strain cleared -
exposed to B strain 
— — 4 - 4X unexposed control -
8-week-old 
VIII 95 4 - 5X D-1 strain cleared -
exposed to B strain 
— — 
— — 6 - 5X unexposed control -
8-week-old 
VIII 113 4 - 5X D-1 strain cleared -
exposed to B strain 
VII 90 8 - 3X D-1 strain cleared -
unexposed to B strain 
VII 90 4 - 3X unexposed control 
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and B. pertussin antigens was 5.0 percent NaCl while diluent 
for antisera dilutions with Salmonella spp. antigens was 2.5 
percent NaCl. Diluent was added to all the wells in 0.05 ml 
amounts with a dropper^ and 0.05 ml of serum was added to the 
first well. Dilutions were made with a diluter^ which carried 
0.05 ml of fluid from one well to the next to give 2-fold 
dilutions. 
Five one-hundredth ml of the appropriate antigen dilution 
was added to each well. The plate was then covered with a 
2 plastic sealer, shaken for 2 minutes on a shaker apparatus , 
and incubated at 37° C for 2 hours. The trays were placed at 
4-8° C for 20 to 40 hours. The results were read, following 
incubation, with the aid of a mirror and recorded. The length 
of time for incubation at 4-8° C was determined by the presence 
of buttons in the control wells containing 0.85 percent NaCl 
instead of antisera. 
The proper antigen dilution was determined by block titra­
tions with several sera from different sources. The B. bronchi-
septica antigen was diluted in 0.85 percent NaCl to 50 nephelos 
units on a Nepho-Colorimeter at a standard of 79 at an expanded 
scale of 4x. This dilution of antigen contained approximately 
8.7 X 10^ colony forming units per ml and was less than a tube 
1 McFarland nephelometer in opacity. 
^Cooke Engineering Company, Alexandria, Virginia. 
^Arthur H. Thomas Company, Philadelphia, Pennsylvania. 
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The B. pertussis antigen was diluted in 0.85 percent NaCl 
to a tube 4 McFarland nephelometer which contained approximately 
g 
1.78 X 10 colony forming units per ml. Bordetella bronchisep-
tica and B. pertussis live antigens were utilized in the test 
within 48 hours of harvest. 
The Salmonella spp. antigens were diluted in 0.85 percent 
NaCl to a tube 2 McFarland nephelometer. 
Microagglutination test (MAT) 
This test was performed by the same method as the PAST. 
Results for the PAST were recorded, the trays remained at room 
temperature for 1 to 2 hours and then were shaken for 10 minutes 
on a shaker apparatus. The plastic sealer was removed and the 
contents of each well was observed through a dissecting micro­
scope at 28x magnification for evidence of agglutination. 
Tube agglutination test 
The test was performed in 8 x 75 mm glass tubes. Diluent 
with B. bronchiseptica antigens was 5.0 percent NaCl while 
diluent for Salmonella spp. antigens was 2.5 percent NaCl. Two­
fold dilutions were conducted with each sera with individual 
plastic serological pipettes. Each dilution of the sera and a 
0.85 percent NaCl control was pipetted back into tubes in 0.5 
ml amounts. 
Five tenths ml of the appropriate antigen dilution was 
added to each tube. The rack of tubes was placed in a plastic 
bag, sealed; and incubated for 2 hours at 37° C followed by 
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20-24 hours at 4-8° C. The results were read, following 
incubation, by visual inspection of tubes shaken by hand. End-
points were based on the last tube to show clumping of the 
antigen. 
The proper antigen dilution was determined by block titra­
tion. The B. bronchiseptica antigen was diluted in 0.85 percent 
NaCl to 110 nephelos units on a Nepho-Colorimeter adjusted to a 
standard of 79 at an expanded scale of 4x. The Salmonella spp. 
antigens were diluted in 0.85 percent NaCl to a tube 2 McFarland 
nephelometer. 
Plate agglutination test 
The test was performed by mixing 0.05 ml of antigen and 
0.05 ml of diluted serum, gently rotating the glass plate at 2-
minute intervals, and examining the antigen-serum mixture for 
agglutination at the end of 8 minutes. Endpoints were based on 
the last dilution to show clumping of the antigen. The dilution 
of the serum was conducted as in the tube agglutination pro­
cedure . 
The proper antigen dilution was determined by block titra­
tion. This dilution v/as too concentrated to measure by compara­
tive nephelometry but was approximately 25x more concentrated 
than the antigen dilution used in the PAST. 
Direct hemagglutination inhibition test (HAI) 
Four- to 8-week-old swine from the source herd were bled 
f 
on the day of the test. The blood was collected aseptically 
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in heparin and washed 3 times with VBD. Erythrocytes were 
resuspended at a 1 percent concentration in VBD. Bordetella 
bronchiseptica strain D-1 grown on 5 percent horse blood agar 
for 40-48 hours was suspended in PBS containing 0.01 percent 
cysteine hydrochloride, pH 7.4. 
Serial 2-fold dilutions of the D-1 strain suspension were 
made in sterile screw-capped glass tubes. Five one-hundredth 
ml of PBS was added to 12 wells of a plastic tray (U-shaped 
wells) and 0.05 ml of each dilution of the suspension was then 
added to each of the wells. Twenty-five thousandth ml of 1 
percent erythrocyte suspension was added to each well and the 
tray was covered with a plastic sealer. The tray was shaken 
for 2 minutes on a shaker apparatus, incubated for 1 hour at 
37° C, and read with the aid of a mirror. The reciprocal of 
the last dilution exhibiting agglutination of the erythrocytes 
was recorded as the titer of hemagglutinin present in the 
suspension. 
Dilutions of antiserum were made in PBS. This diluent was 
added in 0.05 ml amounts to all wells except the 1st well in 
the series. One-tenth ml of serum or nasal wash was added to 
the 1st well and dilutions were made with a diluter which 
carried 0.05 ml of fluid from 1 well to the next, giving 2-fold 
dilutions. Two units of hemagglutinin were added to each well 
in 0.05 ml of fluid. Twenty-five thousandth ml of 1 percent 
erythrocytes was added to each well and the tray was covered 
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with a plastic sealer. The tray was then shaken for 2 minutes 
on a shaker apparatus, incubated 1 hour at 37° C, and then 
incubated at 4-8° C for 18 hours. Each tray contained both a 
positive and a negative control. The results were read with 
the aid of a mirror and recorded. 
Opsonocytophagic test 
Bordetella bronchiseptica strains B and D-1 (passage 9) 
were stored on tryptose blood agar (without blood) slants at 
4-8° C. Broth was inoculated from the slants and incubated for 
48 hours at 37° C. Broth was added to the D-1 strain growth 
until the opacity of the tube was similar to the opacity of the 
growth in tube containing the B strain. A 1:100 dilution of 
these suspensions registered approximately 10 nephelos units on 
a Nepho-Colorimeter at a standard of 20. The adjusted broth 
cultures each contained approximately 1.1 x 10^ colony forming 
units per ml. 
Four- to 8-week-old swine from the source herd were bled 
on the day of the test. The blood was collected aseptically in 
heparin. The sera (diluted 1:4 in 0.85 percent NaCl) or nasal 
wash (concentrated) were sterilized by passage through 0.45 
micron APD cellulose membrane filters. 
The test system consisted of the following placed in 
sterile screw-capped glass tubes: (1) 0.2 ml of the adjusted 
broth culture, (2) 0.2 ml of fresh heparinized swine blood, and 
65 
(3) 0.2 ml of serum or nasal wash. The tubes were placed in a 
drum revolving at 3 to 4 RPM and incubated at 37° C for 1 hour. 
Smears were made on glass slides, air dried, fixed in methyl 
alcohol for 2 minutes, and stained with 2 percent Giemsa stain 
for 15 minutes. 
One hundred mature polymorphonuclear cells were observed 
microscopically in each smear. The number of cells containing 
bacteria (percent phagocytosis) and the number of bacteria in 
the 100 cells were determined (phagocytic index). The phago­
cytic index was calculated by dividing the number of bacteria 
present in 100 cells by 100. 
Bactericidal test 
Bordetella bronchiseptica strain B (passage 9) was stored 
on tryptose blood agar base (without blood) slants at 4-8° C. 
Broth was inoculated from slants and incubated for 18 hours at 
37° C. The culture was diluted with broth to a 36 nephelos 
units reading on a Nepho-Colorimeter at a standard of 20. The 
complement was obtained from the serum of a 6-week-old pig from 
the source herd. The sera, nasal washes, and normal swine serum 
(as a source of complement) were diluted and filter sterilized 
as previously described. 
The test solution consisted of the following placed in 
sterile screw-capped glass tubes: (1) 0.5 ml of the adjusted 
broth culture, (2) 0.3 ml of the serum or nasal wash, and (3) 
0.2 ml of normal swine serum for complement. The tubes were 
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placed in a 37° C waterbath for 1 hour. One ml of the test 
solution was pipetted into glass tubes containing 9.0 ml of 
sterile 0.85 percent NaCl solution. Serial 10-fold dilutions 
were made and 1 ml of each dilution was placed in sterile 
plastic petri dishes. Tryptose blood agar base (without blood), 
maintained at 50" C, was added to the petri dishes and the 
dishes rotated by hand for thorough mixing. The agar was 
allowed to solidify and the dishes were incubated at 37° C for 
n 
48 hours. Tim number of colonies was recorded from the 10 
dilution of the test solution. 
Agglutination of Erythrocytes 
and Epithelial Cells 
Suspensions of B. bronchiseptica, B. pertussis, Haemophilus 
spp., and P. multocida were grown on agar surfaces, suspended 
in PBS with 0.01 percent cysteine hydrochloride, washed 3 times 
in PBS and diluted in serial 2-fold dilutions in PBS. Erythro­
cytes from various animal species were collected in heparin or 
citrate anticoagulant, washed 3 times in VBD, and resuspended 
at a concentration of 1 percent in VBD. Hemagglutinin titra­
tions were performed as previously described in plastic trays 
with U-shaped wells. 
Swine nasal epithelial cells were collected by scraping 
the mucosa of the turbinates and median septum with a sterile 
glass microscope slide. The epithelial cells were suspended in 
VBD and pipetted vigorously to disperse the cells. The 
6 7  
epithelial cells were washed 3 times in VBD and resuspended at 
a concentration of 5 percent in VBD. Twenty-five one hundredth 
ml of 0.25 percent sheep or swine erythrocytes, 0.25 ml of 
epithelial cells, and 0.5 ml of concentrated B. bronchiseptica 
cells were mixed and incubated for 30 minutes at 37° C. A wet 
mount preparation of the mixture was examined by light micro­
scopy. A control mixture containing erythrocytes and epithe­
lial cells without B. bronchiseptica cells was also observed 
microscopically. 
Phagocytosis of Bordetella bronchiseptica 
These determinations were performed as previously described 
for the opsonocytophagic test except 0.2 ml of serum or nasal 
wash was replaced with 0.2 ml of 0.85 percent NaCl in the test 
solution. 
Statistical Analysis 
Chi-square and analysis of variance calculations were con­
ducted as described in Snedecor and Cochran (1967). 
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RESULTS 
Swine Experiments 
Infection of the swine nasal cavity with virulent Bordetella 
bronchiseptica (B strain) and clearance by sulfonamide therapy 
to induce resistance 
Experiment I Ten 4-week-old pigs were inoculated intra­
nasal ly with virulent B. bronchiseptica (B strain) on day 1. 
On day 9, all swine were culturally positive for the organism 
and a sulfonamide^ was administered via the feed (11 Gm./100kg.) 
to the swine. The sulfonamide therapy was discontinued on day 
33 at which time the organism was no longer present in the nasal 
cavity. On day 40, the 10 principal swine and 5 unexposed 
control swine of the same age were inoculated once intranasally 
with virulent B. bronchiseptica (B strain). 
On day 47, the nasal secretions of the 10 drug-cleared 
swine and 2 of the 5 control swine were negative for the organ­
ism. On day 67, the nasal secretions of 8 of 10 drug-cleared 
swine and 1 of 5 control swine were negative for the organism. 
Experiment II Four 8-week-old pigs were inoculated 
intranasally on days 1, 3, and 5 with virulent B. bronchiseptica 
(B strain). On day 36, all swine were culturally positive for 
the organism and the serum titers ranged from 8 to 32. A sul­
fonamide^ was administered via the feed (11 Gm./lOO kg.) to the 
^Sulfamethazine, American Cyanamide Company, Princeton, 
New Jersey. 
swine and continued to day 66. On day 66 the organism was no 
longer present in the nasal secretions, and serum titers of the 
swine ranged from 4 to 16. The 4 principal swine and 2 un­
exposed control swine of the same age were inoculated intra-
nasally on days 88, 90, and 92 with virulent B. bronchiseptica 
(B strain). On day 88, the serum titers of the principal swine 
ranged from 4 to 8. 
Nasal secretions were collected on day 99; three of the 4 
principal swine (1 sample was lost) were negative, and. the 2 
control swine were positive for the organism. Nasal secretions 
were collected at necropsy on day 12 3; the 4 principal swine 
were negative, and the 2 control swine were positive for the 
organism. At necropsy the serum titers of the principal swine 
ranged from 8 to 16, and the control swine were both 32. Macro­
scopic lesions were not observed at necropsy in either principal 
or control swine. Microscopically, the epithelium of the 
ventral turbinates of the control swine was hyperplastic and 
contained microabscesses filled with segmented neutrophils. 
Epithelial damage was not observed in the turbinates of the 
principal swine. Both principal and control swine turbinates 
contained focal accumulations of pyroninophilic mononuclear 
cells in the lamina propria. 
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Infection of the swine nasal cavity with low-virulence 
Bordetella bronchiseptica (D-1 strain) and recovery from infec­
tion by natural elimination to induce resistance 
Experiment III Four 4-week-old pigs were inoculated 
intranasally on days 1, 3, and 5 with low-virulence B. bronchi­
septica (D~l strain, egg passage). On day 11, the nasal secre­
tions of 3 of the 4 principal swine were positive for the 
organism. Nasal secretions collected on day 25 from all 4 
swine were negative for the organism. The 4 principal swine 
and 4 unexposed control swine of the same age were inoculated 
intranasally on day 32 with virulent B, bronchiseptica (B 
strain). 
Nasal secretions were collected on day 39; the 4 principal 
swine- were negative, and the 4 control sv;j.ne were positive for 
the organism. The 4 principal swine and the same 4 control 
swine v/ere inoculated intranasally on days 51, 52, and 54 with 
virulent B. bronchiseptica (B strain). Nasal secretions were 
collected -jri day o2; the 4 principal .«wine were negative, and 
the 4 control swine were positive for the organism. The 4 
principal swine were inoculated intranasally on days 69, 70, 71, 
72, 73, 74, 75, 7G, 77, and 7B with virulent B. bronchiseptica 
(B strain). Nasal secretions collected from the principal 
swine on days 72 and 83 were negative for the organism although 
1 sample was not interpretable on day 83 due to bacterial over­
growth . 
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Experiment IV Twelve 6 to 8-week-old pigs were inocu­
lated intranasally on days 1 and 3 with low-virulence B. 
bronchiseptioa (D-1 strain). Nasal secrotions were collected 
on day 6. Ej.n^^en of the swine were positive for the organism 
while 1 sample was not interpretable due to bacterial over­
growth. Op. Ii.v 12, one pig was destroyed because of a rectal 
prolapse. Nasal secretions were again collected on day 26 at 
which time only 1 of the 11 swine was positive for the organism. 
All 11 nasal secretions collected on day 40 were negative for 
B. bronchiseptica. Three of the principal swine and 4 unexposed 
control swine of the same age were moved to a separate isolation 
unit and inoculated intranasally with virulent B. bronchiseptica 
(B strain) on days 40, 42, and 44. Nasal secretions were col­
lected on day 50; the 3 principal swine were negative, and 2 of 
the 4 control swine were positive for the organism. 
Four additional principal swine and 2 unexposed control 
swine of the same age were moved to a separate isolation unit 
and inoculated intranasally with virulent B. bronchiseptica (B 
strain) on days 95, 9 7, and 99. Nasal secretions were collected 
on day 105; the 4 principal swine were negative, and the 2 
control swine were positive for the organism. 
The 4 remaining principal swine and 2 unexposed control 
swine of the same age were inoculated intranasally with virulent 
B. bronchiseptica (B strain) on days 125, 127, and 129. Nasal 
secretions were collected on day 135. The 4 principal swine 
were negative, and the 2 control swine were positive for the 
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organism. A summary of the bacteriologic data from Experiment 
IV is presented in Table 5. 
Experiment V Eight 2-week-old pigs were inoculated 
intranasally on days 1., 3, and 5 with low-virulenco B. ]ironchi-
septica (D-1 strain). Nasal secretions were collectcd on day 
12; seven of the swine were positive for the organism while 1 
sample was not interpretable due to bacterial overgrowth. On 
day 37, one pig died as a result of a Severn diarrhea. All the 
nasal secretions of the swine were negative for B. bronchi-
septica on day 43. 
On day 56, the 7 principal swine and 4 unexposed control 
swine of the same age were inoculated both intranasally and 
intratracheally with virulent B. bronchiseptica (B strain). On 
days 58 and 60, all swine were inoculated intranasally. On day 
56, the serum titer of 1 principal pig was 4 while the other 
6 principal swine serum titers were negative. On day 63, two 
principal swine and 1 control swine were necropsied. On day 
65, all of the remaining principal and control swine were 
necropsied. Macroscopic lesions were not present. 
A summary of the incidence of B. bronchiseptica recovered 
from the respiratory tract secretions of the pigs in Experiment 
V is presented in Table 6. At necropsy the serum titers for 4 
of the principal swine were negative. The other 3 had titers 
of 4f 4, and 16. The serum titers of the 4 control swine were 
negative, 8, 16, and 32, respectively. 
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Table 5. Incidence of Bordetella bronchiseptica in nasal 
secretions of swine recovered from infection with 
low-virulence D-1 strain and subsequently inoculated 
with virulent B strain (Experiment IV) 
First day of Number of swine 
Bj bronchiseptica yielding B. 
Number of (B strain) bronchiseptica in 
Swine swine inoculation^ nasal secretions^ 
Principals 3 40 0 
4 95 0 
4 125 0 
Controls 4 40 
2 95 
2 125 
^Number of days after principals were first exposed to 
low-virulence B. bronchiseptica (D-1 strain). 
^Based on recovery of B. bronchiseptica from samples of 
nasal secretions collected 10 days after swine were intranasally 
inoculated with B. bronchiseptica (B strain). 
Microscopically, the turbinates of the positive control 
swine exhibited mild epithelial hyperplasia, and the exudate on 
the surface of the epithelium contained many neutrophils. The 
turbinates of the principal swine all contained focal accumula­
tions of mononuclear cells in the lamina propria although the 
epithelium appeared normal. These accumulations were in greater 
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Table 6. Incidence of Bordetella bronchiseptica in respiratory 
tract of swine recovered from infection with low-
virulence D-1 strain and subsequently inoculated both 
intranasally and intratracheally with virulent B 
strain (Experiment V) 
Number of swine yielding 
B. bronchiseptica in 
respiratory tract 
Swine 
Number of 
swine 
Day of 
a 
necropsy Turbinates Trachea Lung 
Principals 2 7 0 0 0 
5 9 0 0 0 
Controls 1 7 1 1 1 
3 9 3 3 0 
^Day swine were killed after first intranasal challenge 
inoculation with virulent B. bronchiseptica (B strain). 
Principal swine were first exposed to low-virulence B. 
bronchiseptica (D-1 strain) 56 days prior to challenge by B 
strain. 
numbers in the ventral scroll of the ventral turbinate. Sec­
tions of the tracheas and lungs of the control and principal 
swine were normal. 
Experiment VI Eight 2-week-old pigs were inoculated 
intranasally on days 1, 3, and 5 with low-virulence B. bronchi­
septica (D-1 strain). Experiment VI was initiated on day 1 of 
Experiment V, and the same inoculation culture of B. bronchi­
septica (D-1 strain) was utilized. Two principal swine and 1 
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previously unexposed control swine of the same age were 
necropsied on days 8, 15, 22, and 29. The bacteriologic re­
covery and macroscopic lesions observed at necropsy are sum­
marized in Table 7. 
Microscopic lesions of the nasal turbinates included 
epithelial hyperplasia, microabscesses in the epithelium, and 
cilia loss in the principal swine necropsied on day 8, 15, 22, 
and 29. The principal swine necropsied on day 15 and 22 had 
hypoplasia of the turbinate osseous core, microscopically. 
diffuse infiltration of mononuclear cells in the turbinate 
lamina propria of the principal swine was present in those 
necropsied on day 22 and 29. Microscopically, the lungs of 4 
of the principal swine contained neutrophils in the alveoli and 
bronchioles and mild alveolar wall thickening. The tracheas of 
the principal swine appeared normal. Lesions were not observed 
microscopically in the respiratory tract in any of the unex­
posed control swine. 
Experiment VII Eight 2-week-old pigs were inoculated 
intranasally on days 1, 3, and 5 with low-virulence B. bronchi-
septica (D-1 strain). Nasal secretions collected from 4 of the 
swine were positive for the organism on day 21, while 2 samples 
were not interpretable due to bacterial overgrowth. All nasal 
secretions were negative for B. bronchiseptica on day 61. On 
day 62, the serum titers were negative from 3 of the swine while 
4 had titers of 8, 8, 8, and 16 (1 sample was not obtained). 
Table 7. Incidence of Bordetella bronchiseptica and macroscopic lesions in respiratory 
tract of swine infected with low-virulence D-1 strain (Experiment VI) 
Group 
B. bronchiseptica 
Day post- Recovered in respiratory secretions 
infection Turbinates Trachea Lung 
Macroscopic lesions 
Turbinate 
hypoplasia Pneumonia 
Principal 
Principal 
Unexposed 
control 
8 
8 
+ 
+ 
Principal 
Principal 
Unexposed 
control 
15 
15 
(purulent exudate) 
(purulent exudate) 
Principal 
Principal 
Unexposed 
control 
22 
22 
+ 
+ 
(unilateral) 
Principal 
Principal 
Unexposed 
control 
29 
29 
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On day 90, the 8 principal swine and 4 unexposed control 
swine of the same age were inoculated intranasally with virulent 
B. bronchiseptica (B strain). Nasal washings were collected 
from 2 principal and 2 control swine at 0.5, 2, 6 and 26 hours 
postinoculation. These nasal washings were cultured to deter­
mine the number of bacteria in both the whole nasal wash and in 
the supernatant after centrifugation (10 minutes at 65 xg). 
The number of B. bronchiseptica recovered from the nasal 
washings collected on day 90 and 91 is presented in Table 8. 
The sediment from the centrifuged nasal washings contained 
epithelial cells, neutrophils, and mononuclear cells. The sedi­
ments of principal and control swine appeared similar at each 
interval. Nasal secretions were collected from 2 principal and 
2 control swine (different from the swine used for nasal 
washing collection) at 6 and 26 hour intervals from the time of 
intranasal inoculation. The nasal secretions of the 2 principal 
swine were negative; and 1 of the 2 control swine was positive 
for B. bronchiseptica at 6 and 26 hour postinoculation. 
On day 105, one principal pig died probably from the 
porcine stress syndrome. On day 107, the 7 principal swine and 
the 4 previously exposed control swine were inoculated intra­
nasally with virulent B. bronchiseptica (B strain). One 
principal and 1 previously exposed control swine were necropsied 
between 1 and 2 hours after this intranasal inoculation. Nasal 
and tracheal washings were collected at necropsy and cultured 
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Table 8. Incidence of Bordetella bronchiseptica in nasal 
washings of swine recovered from infection with low-
virulence D-1 strain and subsequently inoculated 
with virulent B strain (Experiment VII, days 90 and 
91) 
Group 
Pig 
number 
Time post-
inoculation 
(hours) 
Number of colony-forming units 
of B. bronchiseptica recovered 
from the nasal washings per ml. 
Whole Supernatant 
Principal 83G 0.5 4.16 X 10^ 2.28 X 10 
Principal 61G 0.5 7.6 X 10" 8.8 X 10"^ 
Control 82B 0.5 3.9 
o
 
1—1 X 2.1 X lo"^ 
Control BOG 0.5 8.6 X 10 8.0 X 10^ 
Principal 83G 2 0 0 
Principal 61G 2 0 0 
Control 82B 2 3.8 X 10^ 3.1 X 10^ 
Control 80G 2 1.3 X lo"^ 4.8 X 10^ 
Principal 83G 6 2 X 10° 0 
Principal 61G 6 0 0 
Control 82B 6 1.6 X 10^ 0 
Control 80G 6 2.4 X 10^ 1.0 X 10^ 
Principal 83G 26 0 0 
Principal 61G 26 0 0 
Control 82B 26 2.4 X 10^ 8.4 X 10^ 
Control 80G 26 4.0 X 10^ 8.0 X 10^ 
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to determine the number of bacteria in both the whole wash and 
in the supernatant after centrifugation (10 minutes at 65 xg) . 
In the principal swine, the nasal wash did not contain B. 
bronchiseptica while the tracheal whole wash contained 2 x 10 
colony-forming units per ml, and the supernatant contained 
2 1.8 X 10 colony-forming units per ml of the organism. In the 
3 
control swine, the whole nasal wash contained 3.2 x 10 colony-
3 forming units per ml while the supernatant contained 4,4 x 10 
colony-forming units per ml. of B. bronchiseptica. Both the 
whole and supernatant tracheal wash obtained from the control 
2 
swine contained 4 x 10 B. bronchiseptica colony-forming units 
per ml. The serum of the control swine had a titer of 32 while 
the principal swine had a titer of 8 at necropsy. 
On day 116, one principal swine was necropsied and B. 
bronchiseptica was not recovered from the nasal and tracheal 
secretions. A serum sample was not obtained. Three swine were 
necropsied on day 126; a principal, a previously exposed con­
trol, and a previously unexposed control. Bordetella bronchi­
septica was recovered from the nasal secretions of the pre­
viously exposed control swine but not from the principal and 
unexposed control swine. The principal swine had a serum titer 
of 64 while serum samples from the 2 control swine were not 
obtained. 
On day 130, the 4 remaining principal swine were inoculated 
intranasally with virulent B. bronchiseptica (B strain). The 4 
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principal and 1 previously unexposed control swine of the same 
age were necropsied on day 137. The nasal secretions did not 
contain B. bronchiseptica, and the serum titer was negative for 
the principals and the control swine. 
Macroscopic lesions were not observed in the turbinates of 
any swine. Microscopically, 7 of the principal swine turbinates 
contained dense focal accumulations of mononuclear cells in the 
lamina propria while the epithelium appeared normal. The 
eighth section was lost. Two of the exposed control swine tur­
binates exhibited epithelial hyperplasia, some cilia loss, 
microabscesses in the epithelium, and diffuse distribution of 
mononuclear cells in the lamina propria. Necropsies were not 
performed on the other 2 exposed control swine. The 2 unex­
posed control swine turbinates appeared normal microscopically. 
Experiment VIII Four 3-week-old pigs were inoculated 
intranasally on days 1, 5, and 7 with low-virulence B. bronchi­
septica (D-1 strain). Nasal secretions were collected on day 
17; 1 of 3 pigs was positive for B. bronchiseptica while 1 
sample was not interpretable due to bacterial overgrowth. The 
serum titers were negative for 2 swine and were 4 and 32 for the 
other swine. All nasal secretions were negative for the organ­
ism on day 43. On day 53, the serum titers were negative for 
2 swine and were 4 and 8 for the other swine. On days 53, 55, 
and 57, the 4 principal swine and 2 previously unexposed control 
swine of the same age were inoculated intranasally with virulent 
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B. bronchiseptica (B strain). Nasal secretions were collected 
on day 61; the 4 principal swine were negative, and 1 of the 
2 control swine was positive for the organism. 
On day 67, the serum titers of 3 principal pigs were 4 
(1 sample was not obtained). The 2 control swine serum titers 
at this time were negative and 32. On days 67, 70, 80, and 
112, the 4 principal swine and the same control swine were 
inoculated intranasally with virulent B. bronchiseptica (B 
strain). Necropsies were performed on day 130; serum titers 
for the principal were negative, 4, 4, and 16. Serum titers 
for the control swine were negative and 16. The nasal secre­
tions were negative for B. bronchiseptica for both principal 
and control pigs at necropsy. 
Macroscopic lesions were not observed. Microscopically, 
the changes in the turbinates of the principal swine varied 
from a mild epithelial hyperplasia with a diffuse increase of 
mononuclear cells in the lamina propria to normal epithelium 
and focal accumulations of mononuclear cells (Figure 2). The 
turbinates of the infected controls contained focal accumula­
tions of mononuclear cells in the lamina propria with normal 
appearing epithelium. All focal accumulations of mononuclear 
cells contained many pyroninophilic cells (Figure 3). Micro­
scopic lesions were not observed in the tracheas of either 
principal or control swine. 
Figure 2. A focal, ac cuirai 1 at ion cf ^onnnucloar cmlls in the 
lamina propria of a turbinate from a pig cleared 
of Bordetella bronchiseptica low-virulence D-1 
strain infection and subsequently inoculated 
intranasally with virulent B strain. This pig 
was resistant to virulent strain challenge and 
had heej. inoculated intranasally with the 
organism 73 days before necropsy (Experiment 
VIII). Hematoxylin and eosin Jtain. 159x 
Figure 3. Tlie pyroninophilic nature of a focal accumulation 
of mononuclear cells from Figure 2 is demon­
strated by high magnification (Experiment VIII). 
Methyl greon-pyronine stain. 1240x 
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A summary of the incidence of B. bronchi s eptica recovered 
from the nasal secretions of principal and control swine from 
Experiments I, II, III, IV, V, and VIII is presented in Table 9. 
Experiment IX Four 2-week-old pigs were inoculated 
intranasally on days 1 and 3 with low-virulence B. bronchisep-
tica (D-1 strain). One pig died on day 9 due to starvation 
caused by early weaning. Nasal secretions collected on day 9, 
from the 3 remaining swine, were positive for the organism. On 
days 9, 11, and 14, the 3 principal and 3 unexposed control 
swine of the same age were inoculated with virulent B. bronchi-
septica (strain IVDL 374). Nasal secretions were collected on 
days 18, 32, 41, 47, 55, and 65; the 3 principal and 3 control 
pigs were positive for B. bronchiseptica. 
Biochemically, cultures of D-1 strain were nitrate nega­
tive, and strain IVDL 374 were nitrate positive when inoculated 
into the experimental swine on days 9, 11, and 14. During the 
course of the experiment, representative colonies of B. bronchi­
septica were picked from the plates previously inoculated with 
nasal secretions and nitrate reactions determined. The number 
of colonies picked varied from 1 to 10 per plate. 
On day 18, only nitrate positive B. bronchiseptica were 
recovered from the control swine while both nitrate positive 
and negative organisms were isolated from the principal swine. 
On days 32, 41, and 47, the principal swine harbored both 
nitrate positive and negative B. bronchiseptica; nitrate 
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Table 9. Summary of the recovery of Bordetella bronchiseptica 
from the nasal secretions of principal and control 
swine from Experiments I, II, III, IV, V, and VIII 
Number of swine 
positive for B. 
bronchiseptica 
between 7 to 11 
days after intra­
nasal inoculation 
Number of with virulent B Chi Square 
Treatment swine strain value 
Principal swine 14 0 9.454** 
cleared of B 
strain infection 
by sulfonamide 
therapy 
Controls 7 5 
Principal swine 26 0 24.374** 
cleared of D-1 
strain infection 
by natural 
elimination 
Controls 14 11 
Significant at p < 0.01 level. 
determinations were not made on the control swine isolates on 
those days. On days 55 and 65, the principal swine isolates 
were all nitrate positive; however, the control swine contained 
some nitrate negative isolates on day 65. 
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All pigs were necropsied on day 78. The bacteriologic 
recovery and macroscopic lesions observed at necropsy are 
presented in Table 10. Microscopically, the turbinates of both 
control and principal swine had epithelial hyperplasia, cilia 
loss, and microabscesses in the epithelium. The turbinate 
osseous core of 2 control swine and 1 principal swine was 
hypoplastic, and replacement fibrosis was present. The lung of 
1 control pig had thickened alveolar walls and peribronchiole 
fibrosis. The tracheas of both control and principal swine 
appeared normal. 
Experiment X Four 8-week-old pigs were inoculated 
intranasally on day 1 with 1 ml per pig of a 4 percent acetic 
acid solution and a broth culture containing a 21st passage of 
an atypical colony form of low-virulence B. bronchiseptica 
(D-1 strain). This atypical form grew on MacConkey's agar as 
a small colony with a large central elevation which had been 
selected during 21 passages in artificial media. Nasal 
secretions were collected on day 13; 3 of the 4 swine were 
positive for the organism. Nasal secretions were collected on 
day 38; all swine were negative for B. bronchiseptica. On days 
38, 40, and 48, the 4 principal swine and 2 unexposed control 
swine of the same age were inoculated intranasally with virulent 
B. bronchiseptica (B strain). Nasal secretions were collected 
on day 48, 2 of the 4 principal and the 2 control swine were 
positive for the organism. The swine were necropsied on day 53. 
Table 10. Incidence of Bordetella bronchiseptica and macroscopic lesions in 
respiratory tract of swine inoculated with low-virulence D-1 strain and 
challenged 8 days later with virulent IVDL 3 74 strain (Experiment IX) 
Bordetella bronchiseptica Macroscopic 
lesions 
Pig Turbinate 
number Groupé Turbinates Trachea Lungs hypoplasia Pneumonia 
61 control + - + + 
(mild) 
72 control — — — — 
65 control — — — -f — 
(severe) 
21 principal — — 
(mild) 
73G principal — — — — — 
73B principal — 
The principal swine were inoculated with D-1 strain B. bronchiseptica on days 
1 and 3. Both principal and control swine were inoculated with IVDL 374 strain of 
B. bronchiseptica on days 9/ 11, and 14. 
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The nasal secretions of 3 of the 4 principal and the 2 control 
swine were positive for the organism. Macroscopically, the 
turbinates appeared normal. Microscopically, both the controls 
and principal swine turbinates exhibited epithelial hyperplasia 
with cilia loss. The turbinate r.sceous core of 1 principal pig 
was hypop1as ti c. 
Subcutaneous injection of swine with either sonicly disrupted 
Bordetella bronchiseptica (D-1 strain) vaccine or pertussis-
vaccine to induce respiratory resistance 
Experiment XI Four 4-week-old pigs were injected 
subcutaneously with sonicate-vaccine on days 1 and 6. Two of 
the vaccinated pigs and 2 unvaccinated controls of the same age 
were inoculated intranasally with virulent B. bronchiseptica 
(B strain) on days 12, 15, and 17. On day 28, nasal secretions 
from the principal swine were negative and 1 of the control 
swine was positive for B. bronchiseptica while 1 control swine 
sample was not interpretable due to bacterial overgrowth. Nasal 
secretions collected on days 42 and 79; the vaccinated 
swine were negative, and the 2 control swine were positive for 
the organism. 
On days 59, 61, and 63, the other 2 vaccinated swine and 
2 unvaccinated, unexposed control swine of the same age were 
inoculated intranasally with virulent B. bronchiseptica (B 
strain). Nasal secretions were collected on day 70; the 2 
vaccinated and the 2 control swine were positive for the organ­
ism, Nasal secretions were collected on day 79; the vaccinated 
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swine were negative, and 1 of the 2 control swine were positive 
for B. bronchiseptica. Nasal secretions were collected on day 
86 ; 1 of the vaccinated swine and 1 of the control swine were 
positive for the organism. 
Experiment XII Six 4-week-old pigs were injected sub-
cutaneously with sonicate-vaccine on days 1 and 7. One pig 
died on day 13 of unknown causes. On days 14, 17, and 19, 2 
vaccinated swine and 2 unvaccinated control swine of the same 
age were inoculated intranasally with virulent B. bronchiseptica 
(B strain). Nasal secretions were collected on days 21, 26, 
and 41; the 2 vaccinated and the 2 control swine were positive 
for the organism. 
On days 42, 44, and 46, the 3 remaining vaccinated swine 
and 2 unvaccinated, unexposed swine of the same age were inocu­
lated intranasally with B. bronchiseptica (B strain). Nasal 
secretions were collected on day 53; 2 of the 3 vaccinated swine 
and the 2 control swine were positive for the organism. Nasal 
secretions were collected on day 67; the 3 principal swine were 
negative while the 2 control swine were positive for B. bronchi­
septica. 
The swine which were inoculated on days 42, 44, and 46, 
were necropsied on day 79. Nasal and tracheal secretions from 
the 3 vaccinated swine were negative for the organism. Nasal 
secretions from the 2 control swine and tracheal secretions 
from 1 of the control swine were positive for B. bronchiseptica. 
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Macroscopic lesions were not observed in the swine. Micro­
scopically, the turbinates of 1 control and 2 vaccinated swine 
had epithelial hyperplasia with loss of cilia. The trachea of 
1 control swine had epithelial hyperplasia with loss of cilia. 
Experiment XIII Thirty-six pigs were divided equally 
into 3 groups based on age as follows; group 1, 2-week-old; 
group 2, 4-week-old; and group 3, 8-week-old. On day 1 and day 
7 or 8, 4 swine in each group were injected subcutaneously with 
sonicate-vaccine and 4 swine in each group were injected sub­
cutaneously with pertussis-vaccine. The 4 remaining swine in 
each group served as unvaccinated controls. All swine were 
inoculated intranasally with virulent B. bronchiseptica (B 
strain) every other day for 3 days (total of 3 doses). Intra­
nasal inoculations were initiated on day 36 for group 1, day 35 
for group 2, and day 38 for group 3. Nasal secretions and 
blood sduiplci: were colleci.ed at 7 to 4 week intervals. The 
animals were necropsied between days 96 and 105. 
The incidence of B. bronchiseptica in the nasal secretions 
of swine during the experiment is presented in Table 11. The 
average serum agglutinin response against B. bronchiseptica for 
the unvaccinated, infecL^d control swine and the sonicate-
vaccine injected swine is presented in Figure 4. The average 
serum agglutinin response against B. pertussis for the unvac­
cinated, infected control swine and the pertussis-vaccine in­
jected swine is presented in Figure 5. 
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Table 11. Incidence of Bordetella bronchiseptica in the nasal 
secretions of swine injected with either sonicate-
or pertussis-vaccine and inoculated intranasally 
with virulent B strain (Experiment XIII) 
Age in weeks Days after first intranasal 
at time of inoculation of virulent 
fir;-.t In 1 ec':ion B. bronchiseptica (B strain) 
Treatment of vaccine^ 
0 13-15 25 35-40 61-69 
Unvaccinated 2 0/4^ 4/4 4/4 4/4 3/4 
4 0/4 3/3C N.D. 3/3 2/3 
8 0/4 N.D. 3/3C 3/3 3/3 
0/12 7/7 7/7 10/10 8/10 
Sonicate- 2 0/4 4/4 4/4 2/4 0/4 
vaccine /J 
4 0/4 3/3^ N.D. 2/4 0/2° 
8 0/4 N.D. 3/4 3/4 1/4 
0/12 7/7 7/8 7/12 1/10 
Pertussis- 2 0/4 3/4 4/4 2/4 1/4 
vaccine 
4 0/4 2/4 N.D. 2/4 1/4 
8 0/4 N.D. 4/4 4/4 1/4 
0/12 5/8 8/8 8/12 3/12 
^The principal swine were injected with vaccine on days 1 
and 7 or 8. All swine were inoculated intranasally with 
virulent B. bronchiseptica (B strain) between days 35 to 42. 
^Denominator designates number of swine sampled; numerator 
designates number of swine positive for B. bronchiseptica. 
^Sample number decreased due to death of swine during 
experiment. 
^Dne sample not interpretable due to bacterial overgrowth. 
Figure 4. The average serum agglutinin response (PAST) detected against Bordetella 
bronchiseptica antigen in unvaccinated and sonicate-vaccine injected 
swine following challenge with virulent B strain (Experiment XIII) 
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Figure 5, The average serum agglutinin response (PAST) detected against Bordetella 
pertussis antigen in unvaccinated and pertussis-vaccine injected swine 
following challenge with virulent B strain (Experiment XIII) 
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Macroscopically, turbinate hypoplasia was not present in 
any of the swine. Microscopically, the turbinates of 5 un­
vaccinated, infected control swine had epithelial hyperplasia 
with loss of cilia. The turbinates of both unvaccinated and 
vaccinated swine had focal accumulations of mononuclear cellc 
in the submucosa. Most focal accumulations of mononuclear cells 
contained many pyroninophilic cells. Occasionally, a turbinate 
from vaccinated swine had massive accumulations of mononuclear 
cells resembling a lymph nodule (Figures 6 and 7). 
Experiment XIV On days 1 and 6, eight 2-week-old pigs 
were injected subcutaneously with sonicate-vaccine and four 2-
week-old pigs were injected subcutaneously with pertussis-
vaccine. Four of the sonicate-vaccine injected swine and 2 un­
vaccinated control swine of the same age were inoculated intra-
nasally with virulent B. bronchiseptica (B strain) on days 44, 
46, and 50. The antibody titers for the control swine were 2 
and 8 while the titers of the 4 sonicate-vaccine injected swine 
ranged from 1024 to 4096 at this time. 
Nasal secretions were collected on day 63; 3 of the 4 
sonicate-vaccine injected pigs and 1 of the 2 unvaccinated con­
trol swine were positive for the organism. One sample was not 
interpretable due to bacterial overgrowth. On day 65, one un­
vaccinated control pig died of unknown causes. 
Nasal secretions were collected on day 86; 2 of the 4 
sonicate-vaccine injected swine and the 1 unvaccinated control 
Figure 6. A focal accumulation of mononuclear cells present 
in the lamina propria of a turbinate from a pig 
injected with sonicate-vaccine and subsequently 
inoculated intranasally with virulent Bordetella 
bronchiseptica (B strain) (Experiment XIII). 
Hematoxylin and eosin stain. 244x 
Figure 7. An accumulation of mononuclear cells resembling 
a lymph node present in the lamina propria of a 
turbinate from a pig injected with pertussis-
vaccine and subsequently inoculated intra­
nasally with virulent Bordetella bronchiseptica 
(B strain) (Experiment XIII). Hematoxylin and 
eosin stain. 124x 
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pig were positive for the organism. The anLibocly Liter for the 
control pig was 32 while the titers of tlio 4 sonicate-vaccine 
injected swine ranged fron 2 ' . )G  to 512 ac Lii.is time. The swine 
which were inoculated ini;--:.-tlly on day.s 44 , 46, and 50 were 
necropsied on day 10 7, M'h-;- .laSci I s,..' . i. e Li ons of the 4 sonicate-
vaccine injected swin-j wuro neoati-'f. while the nasal secretions 
of the 1 unvaccinated control swiiiu were positive for B. bronchi­
septica. The antibody titer for the control pig was 16 while 
the titers of the 4 sonicate-vaccine injected swine ranged from 
128 to 512 at the time of necropsy. 
The 8 unexposed vaccinabed swine (sonicate- and pertussis-
vaccine injected) and 4 unvaccinated control swine of the same 
age were inoculated intranasally with virulent B. bronchiseptica 
(B strain) on days 116, 118, and 120. The incidence of B. 
bronchiseptica in the nasal secretions of swine during the 
experiment is presented in Table 12. The average serum agglu­
tinin response against B. bronchiseptica for the unvaccinated, 
sonicate-vaccine injected, and pertussis-vaccine injected swine 
is presented in Figure 8. 
A summary and statistical analysis of the data from Experi-
raonts XIII and XIV are presented in Table 13. 
Experiment XV Six 4-week-old pigs were inoculated 
intranasally with virulent B. bronchiseptica (B strain) on days 
1, 3, and 5. Pertussis-vaccine was injected subcutaneously 
into 4 of the previously exposed swine on days 7 and 11. On 
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Table 12. Incidence of Bordetella bronchiseptica in the nasal 
secretions of swine injected with either sonicate-
or pertussis-vaccine before intranasal inoculation 
with virulent B strain (Experiment, XIV) 
Days after 
inoculation 
chiseptica 
the first intranasal 
of virulent B. bron-
(B strain)^ 
Treatment 0 17 40 47 60 
Unvaccinated 
o
 4/4 4/4 4/4 2/4 
Sonicate-vaccine 0/4 2/4 0/4 0/4 0/4 
Pertussis-vaccine 0/4 1/4 1/4 0/3^ 0/4 
^The principal swine were injected with vaccine on days 1 
and 6. All swine were inoculated intranasally with virulent 
B. bronchiseptica (B strain) on days 116, 118, and 120. 
^Denominator designates number of swine sampled; numerator 
designates number of swine positive for B= bronchiseptica. 
^bne sample not interpretable due to bacterial overgrowth. 
day 11, nasal secretions of 3 of 3 vaccinated swine and 1 of 1 
unvaccinated control swine were positive for the organism. Two 
samples were not interpretable due to bacterial overgrowth. 
All swine were positive for the organism on days 20, 28 and 41. 
At necropsy on day 59, 3 of 3 vaccinated swine and 2 of 2 
unvaccinated control swine were positive for the organism. One 
sample was not interpretable due to bacterial overgrowth. 
Figure 8. The average serum agglutinin response (PAST) 
detected against Bordetella bronchiseptica antigen 
in the unvaccinated, sonicate- and pertussis-
vaccine injected swine following challenge with 
virulent B strain (Experiment XIV) 
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Table 13. Summary of the incidence of Bordetella bron-
chiseptica recovered from the nasal secretions of 
principal and control swine from Experiments XIII 
and XIV 
Treatment 
Number of 
swine 
Number of swine 
positive for B. 
bronchiseptica 
between 60-to-69 
days after intra­
nasal inoculation 
of virulent B 
strain 
Chi Square 
value 
Unvaccinated 
controls 14 10 
Sonicate-
vaccine 14 1 9.58** 
Pertussis-
vaccine 16 3 5.02* 
Significant at p £ 0.05 level. 
** 
Significant at p £ 0.01 level. 
Macroscopically, the turbinates of 3 vaccinated swine appeared 
normal. One vaccinated swine and 1 unvaccinated control swine 
had mild turbinate hypoplasia while 1 unvaccinated control 
swine had severe turbinate hypoplasia. 
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Injection of swine with formalized whole cell Bordetella 
bronchiseptica vaccines to induce respiratory resistance 
Experiment 3CVI Four 8-week-old pigs were injected 
intramuscularly with B. bronchiseptica whole cell-vaccine (B 
strain) on days 1, 5, 10, 15, and 20. On days 28, 30, and 32, 
the 4 vaccinated swine and 4 unvaccinated control swine of the 
same age were inoculated intranasally with B. bronchiseptica 
(B strain). The serum antibody response as determined by rapid 
plate agglutination (B strain) was 128, 128, 256, and 256 for 
the vaccinated swine on day 28. 
Nasal secretions were collected on day 42. Three of 4 
vaccinated swine and 4 of 4 unvaccinated control swine were 
positive for the organism. Serum antibody response as deter­
mined by rapid plate agglutination was 16, 16, 16, and 32 for 
the vaccinated swine and negative for all 4 unvaccinated swine. 
Nasal secretions were collected on day 57; 3 of 4 vac­
cinated swine and 3 of 4 unvaccinated control swine were positive 
for B. bronchiseptica. Serum antibody response as determined by 
rapid plate agglutination was 4, 8, 8, and 16 for the vaccinated 
swine and negative for all 4 unvaccinated swine at this time. 
Experiment XVII Four 5-week-old pigs were injected 
subcutaneously with B. bronchiseptica whole cell-vaccine (D-1 
strain) on days 1 and 8. On days 40, 42, and 44, the 4 vac­
cinated swine and 2 unvaccinated control swine of the same age 
were inoculated intranasally with B. bronchiseptica (B strain). 
105 
The incidence of B. bronchiseptica in the nasal secretions 
of swine during the experiment is presented in Table 14. The 
average serum agglutinin response against B. bronchiseptica 
in the unvaccinated swine and the whole cell-vaccine injected 
swine following exposure to virulent B strain B. bronchiseptica 
is presented in Figure 9. 
Subcutaneous injection of pregnant sows with sonicly disrupted 
Bordetella bronchiseptica (D-1 strain) vaccine to induce 
respiratory resistance in newborn pigs 
This series of observations is based on 4 litters of pigs. 
Two of these were farrowed by sows that had been vaccinated and 
2 were from unvaccinated sows. 
Experiment XVIII The first unvaccinated sow farrowed 
11 pigs on day 1. On days 3, 5, and 7, the 7 remaining pigs 
were inoculated intranasally with virulent B. bronchiseptica 
(B strain). The serum titer of the dam was 8 while the titers 
of the pigs varied between 2 and 4 on day 3. 
Nasal secretions were collected on days 14 and 29. On 
both occasions 4 pigs were positive for B. bronchiseptica while 
3 samples were not interpretable due to bacterial overgrowth. 
The antibody titers of the pigs on day 14 were negative or 2 
while on day 29 the titers ranged from negative to 8. 
The pigs were necropsied on day 54 and the serum titers of 
the pigs were negative or 2. The incidence of B. bronchiseptica 
in the respiratory secretions and the macroscopic lesions in the 
pigs at necropsy are presented in Table 15. 
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Table 14. Incidence of Bordetella bronchiseptica in the nasal 
secretions of swine injected with, whole cell-vaccine 
(D-1 strain) before intranasal inoculation with 
virulent B strain (Experiment XVII) 
Days after the first intranasal inoculation 
of virulent B, bronchiseptica (B strain)^ 
Treatment 0 12 20 3 8 60 
Unvaccinated 0/2^ 2/2 2/2 2/2 2/2 
Vaccinated 0/4 1/4 2/4 2/4 0/4 
The principal swine were injected with vaccine on days 1 
and 8. All swine were inoculated intranasally with virulent 
B, bronchiseptica (B strain) on days 40, 42, and 44. 
^Denominator designates number of swine sampled; numerator 
designates number of swine positive for B. bronchiseptica. 
Experiment XIX The second unvaccinated sow farrowed 6 
pigs on day 1. On days 3, 6, and 8, the 5 remaining pigs were 
inoculated intranasally with virulent B. bronchiseptica (B 
strain). The serum titer of the dam was 4 while the titers of 
the pigs varied between 8 and 32. 
Nasal secretions were collected on day 33, 2 pigs were 
positive for B. bronchiseptica while 3 samples were not inter­
prétable due to bacterial overgrowth. The serum titers in the 
pigs at this time were negative. Nasal secretions were 
Figure 9. The average serum agglutinin response (PAST) 
detected against Bordetella bronchiseptica 
antigen in unvaccinated and whole cell-vaccine 
(D-1 strain) injected swine following challenge 
with virulent B strain (Experiment XVII) 
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Table 15. The incidence of Bordetella bronchiseptica and macroscopic lesions in the 
respiratory tract of swine inoculated with virulent B strain after 
nursing unvaccinated sows (Experiments XVIII and XIX) 
B. bronchiseptica 
recovered in respiratory Macroscopic 
secretions on days 54-71 lesions 
Experiment Pig Turbinates Trachea Lung Turbinate Pneumonia 
number number hypoplasia 
XVIII IIG Overgrown^ + - + 
(severe) 
+ 
12G + + + 
(mild) 
13G + + + 
(moderate) 
+ 
14G + + + 
(severe) 
15G + + 
(moderate) 
+ 
16G + + + + 
(severe) 
+ 
17G + + + + 
(moderate) 
+ 
XIX 40G - - - - -
40B + + 
(mild) 
41G + - - - -
4 IB + 
(mild) 
42G - - — - — 
Totals 
r~
\ CO 
5/12 3/12 9/12 5/12 
^Sample not interpretable due to bacterial overgrowth. 
^Denominator designates number of swine sampled; numerator designates number of 
swine positive. 
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collected on day 46; 3 pigs were positive for B. bronchiseptica 
while 2 samples were not interpretable due to bacterial over­
growth . 
The pigs were necropsied on day 71. The serum titers in 
the pigs were 2. The incidence of B. bronchiseptica in the 
respiratory secretions and the macroscopic lesions in the pigs 
at necropsy are presented in Table 15. 
Experiment XX One pregnant sow was injected sub-
cutaneously with sonicate vaccine 34 and 17 days prior to far­
rowing. This vaccine was from the same preparation used in 
Experiment XIV. The serum titer for the sow before vaccination 
was 16 while 26 days after the first vaccination the titer was 
1024. Eleven pigs were farrowed on day 1 which was the 34th 
day after the first vaccination. On days 2, 6, and 8 the 10 
remaining pigs were inoculated intranasally with virulent B. 
bronchiseptica (B strain). The serum titer of the dam was 2048 
while the titers of the pigs ranged from 512 to 409 6 at the 
time of the first inoculation. 
Nasal secretions were collected from the pigs on days 14 
and 22, on both occasions all 10 pigs were positive for B. 
bronchiseptica. Nasal secretions were collected on day 70, 8 
of the 10 pigs were positive for the organism. The serum titers 
of the pigs ranged from 16 to 128 at this time. 
The pigs were necropsied on day 99. The serum titers of 
the pigs ranged from 4 to 128. The incidence of B. bronchisep­
tica in the respiratory secretions and the macroscopic lesions 
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in the pigs at necropsy are presented in Table 16. 
Experiment XXI The second pregnant sow was injected 
subcutaneously with sonicate-vaccine 42 days and again 25 days 
prior to farrowing. This vaccine was from the same preparation 
used in Experiment XIV. The serum titer for the sow prior to 
vaccination was 2 while 26 days after the first vaccination the 
titer was 1024. Five pigs were farrowed on day 1. On days 2, 
6, and 8, the 4 remaining pigs were inoculated intranasally 
with virulent B. bronchiseptica (B strain). The serum titer 
in the dam was 4096 while the titers of the pigs were all 4096 
when the pigs were 2 days of age. 
Nasal secretions were collected from the pigs on days 14 
and 28. All 4 were positive for the organism. The serum titers 
of the pigs ranged from 256 to 1024 on day 28. 
The pigs were necropsied on day 57 at which time the serum 
titers of the pigs ranged from 32 to 256. The incidence of B. 
bronchiseptica in the respiratory secretions and the macro­
scopic lesions in the pigs at necropsy are presented in Table 
16. 
Respiratory resistance to Bordetella bronchiseptica associated 
with age of swine at the time of first intranasal exposure 
Experiment XXII Four 3-week-old pigs (Group 1) and 
four 24-week-old pigs (Group 2) were inoculated with virulent 
B. bronchiseptica (B strain) on days 1, 3, and 6. Two principal 
swine from each age group and 2 previously unexposed control 
Table 16. The incidence of Bordetella bronchiseptica and macroscopic lesions in the 
respiratory tract of swine inoculated with virulent B strain after 
nursing sonicate-vaccine injected sows (Experiments XX and XXI) 
B. bronchiseptica 
recovered in respiratory Macroscopic 
secretions on days 57-91 lesions 
Experiment Pig Turbinates Trachea Lung Turbinate Pneumonia 
number number hypoplasia 
XX 20G - - - - -
20B + — « 4* — 
(moderate) 
21G - - - + -
(mi Id) 
21B + - - + -
(mild) 
22G - - - — — 
22B — — — + -
(mild) 
23G + + - 4* -
(mild) 
23B + - - - -
24G - - - - -
24B + - - - -
XXI 30G - — - + -
(mild) 
30B - - - 4- -
(mild) 
3 IB + - - + — 
(moderate) 
32B + + - 4* -
(moderate) 
Totals 7/14^ 2/14 0/14 9/14 0/14 
^Denominator designates number of swine sampled; numerator designates number of 
swine positive. 
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swine of the same age for each group were necropsied on day 45. 
Macroscopic lesions of turbinate hypoplasia of moderate and 
severe degrees were observed only in the two principal swine 
from group 1. Macroscopic lesions were not observed in the 
respiratory tracts of the other swine. The incidence of B. 
bronchiseptica in the nasal secretions of the swine during the 
experiment is presented in Table 17. 
The 2 remaining principal swine in group 2 which had 
cleared the infection by day 33, and 2 previously unexposed 
swine of the same age were inoculated with virulent B. bronchi­
septica (B strain) on days 59, 61, and 63. Nasal secretions 
were collected on day 67; the principal swine were negative, 
and the control swine were positive for the organism. These 4 
swine were necropsied on day 69 and macroscopic lesions were 
not observed in the respiratory tracts. The nasal secretions 
of all 4 swine were positive for B. bronchiseptica at this time. 
Serologic Tests 
Development of the particulate antigen settling test (PAST) 
Initial attempts to utilize a tube agglutination test for 
the detection of swine antibodies against B. bronchiseptica were 
disappointing in that the sensitivity of the test system was 
apparently low. The tube agglutination test procedure was trans­
ferred to disposable plastic trays in order to facilitate serum 
dilution with micro-titration equipment and to increase ease of 
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Table 17. Incidence of Bordetella bronchiseptica in the nasal 
secretions of 3-week-old and 24-week-old swine 
inoculated intranasally with virulent B strain 
(Experiment XXII) 
Age at the time of the Days after the first intra-
first intranasal inoculation nasal inoculation 
0 12 24 33 45' 
3 weeks 0/4^ 1/2^ 4/4 4/4 l/l' 
24 weeks 0/4 3/4 4/4 0/4 0/2 
^All swine were inoculated intranasally with virulent 
B. bronchiseptica (B strain) on days 1, 3, and 6. 
^Two swine in each age group were sampled on day 45. 
^Denominator designates number of swine sampled; numerator 
designates number of swine positive for B. bronchiseptica. 
"^Some samples not interpretable due to bacterial over­
growth . 
microscopic examination of the agglutination reaction. Agglu­
tination of the antigen by antibodies against B, bronchiseptica 
was observed microscopically after incubation of the test 
plates at 37° C for 2 hours. Further incubation of the test 
plates at 4-8° C for 14 to 24 hours allowed for settling of the 
antigen in the form of either shields (antibody present) or 
buttons (antibody absent) in the wells of the plate (Figure 10). 
Preliminary studies with this system revealed a considerable 
increase in titer for various sera containing antibody against 
Figure 10. The endpoints of the particulate antigen settling 
test were determined by the formation of shields 
(antibody present) and buttons (antibody absent). 
The sera in rows 1, 2, 3, 4, and 5 were from 
experimental pigs which had been exposed to 
Bordetella bronchiseptica either by injection of 
a vaccine or by intranasal inoculation of the 
live organism. The sera in rows 6 and 7 were 
from unvaccinated, unexposed pigs. Row 8 con­
tained 0.85 percent NaCl solution in place of 
serum 
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B. bronchiseptica. Therefore, some cf the parameters of the 
system called the particulate antigen settling test (PAST) were 
determined. 
Diluents containing various concentrations of sodium 
chloride were compared in the PAST with B. bronchiseptica anti­
gens using pooled serum samples from unexposed control, vac­
cinated, and infected swine. The titers obtained when a 
diluent containing either 5.0 percent or 0.85 percent sodium 
chloride was used are presented in Table 18. A diluent con­
taining 5.0 percent sodium chloride was optimal for the PAST 
when B. bronchiseptica antigens were used. By contrast, a 
diluent containing 2.5 percent sodium chloride was optimal for 
the PAST when Salmonella spp. antigens were used. PAST titers 
to B. bronchiseptica obtained with sera from unvaccinated, un­
exposed swine of various ages are presented in Table 19. 
Live and formalin inactivated antigens of B. bronchiseptica 
strains D-1 and B were prepared from agar and broth cultures. 
PAST titers obtained with these antigens are presented in 
Table 20. A 1:1000 concentration of formalin was found to be 
optimal for inactivation of the antigen when incubated at 37° C 
for 24 hours prior to harvest. 
The reproducibility of the PAST was evaluated utilizing a 
formalin inactivated B. bronchiseptica (D-1 strain) broth 
culture antigen. Four lots of antigen which were prepared in a 
similar way on different days are compared in Table 21. The 
1.18 
Table 18. Effect of sodium chloride concentration of the 
diluent on the particulate antigen settling test 
Sample^ Exposure^ and/or vaccination Diluent 
number experience of donor swine 0.85% MaCl 5.0% NaCl 
1 whole cell-vaccine (B strain) 4096^ 512 
- exposed to B strain 
543 pertussis-vaccine - 512 256 
to B strain 
544 sonicate-vaccine - exposer" "2 . 16 , 384 
to B strain 
545 unva c ci n a ted ~ to 16 32 
B str: i.:i 
530 D-1 strain cleared ~ exposed 
to B strain 
572 unexposed control 32 
422 unexposed control 64 
a Formalin inactivated j.ronchisentica (D-1 strain) 
broth culture. 
^Refer to Table 2 for history of sariple source. 
^Intranasal inoculation with B. bronchiseptica (virulent 
B strain or low-virulence D-1 strain). 
'^Titers expressed as the reciprocal of the serum dilution. 
formalin inactivated broth antigen (D-1 strain) was stable for 
at least 90 days when stored at 4-8° C. 
Swine and rabbit antisera against formalin inactivated 
broth B. bronchiseptica (D-1 strain) antigen were compared in 
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Table 19. Titers detected by the particulate antigen settling 
test in serum from unvaccinated, unexposed swine in 
relation to the age of the anjmal^ 
Tite.r^ 
Age at time of collection. 
Total 3 days 2-4 
weeks 
4 — 3 
week 
8-16 
s veeV.s 
over 16 
weeks 
<2 _c 18 9 4 - 31 
2 1 4 18 9 1 33 
4 7 3 3 2 1 16 
8 2 1 — — 1 4 
16 2 - 1 2 3 8 
32 1 - - - - 1 
Total 13 26 31 17 6 93 
^Formalin inactivated B. bronchiseptica (D-1 strain) broth 
culture. 
^Titer expressed as the reciprocal of the serum dilution. 
^Number of swine per age group. 
the PAST, tube, plate, and microagglutination tests (MAT) 
(Table 22). Additional swine sera were tested with formalin 
inactivated broth B. bronchiseptica (D-1 strain) antigen in 
both the PAST and plate agglutination tests (Table 23). Of the 
21 unvaccinated, infected control swine serum samples recorded 
in Table 16, 20 pigs contained titers of 8 or more in the PAST 
as compared to only 2 pigs in the plate agglutination test. 
Table 20. Comparison of various antigen preparations of Bordetella bronchiseptica 
in the particulate antigen settling test 
Antigen preparation 
D-1 strain B strain 
Sample Live, Live, Inact., Inact., Live, Live, Inact., Inact., 
number^ agar broth agar broth agar broth agar broth 
1 IO24C 512 512 1024 512 2048 512 1024 
543 128 512 8 512 512 64 4 512 
544 512 15,384 512 16,384 512 32,768 512 8,19 2 
545 8 32 16 4 8 32 8 
530 8 32 8 32 2 4 2 16 
422 4 4 4 — — 2 - - 4 
532 w —« 16 4 2 4 2 2 
^Refer to Table 2 for history of sample source. 
^Formalin inactivated. 
^Titer expressed as the reciprocal of the serum dilution. 
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Table 21. Comparison of the reproducibility of different lots 
of the inactivated broth antigen of Bordetella 
bronchiseptica (D-1 strain) 
Sample, 
number' A 
Antigen preparation 
B n 
2048' 
1024 
256 
512 
256 
256 
256 256 
128 
128 
543 512 
N.D. 
256 
256 
128 
128 
128 
128 
256 
256 
256 
544 16,3R4 
16,384 
55,536 
32:762 
32,768 
16,384 
4,096 
i,192 
,192 
8,192 
8,192 
530 16 
32 
16 
N.D. 
N.D. 
± c  
16 
N.D. 
N.D. 
N.D. 
N.D. 
422 4 
2 
8 
4 
N.D. 
8 
4 
4 
2 
532 4 
8 
2 
4 
8 
2 
2 
2 
2 
Refer to Table 2 for history of sample source. 
b_. Titer expressed as the reciprocal of the serum dilution. 
Results obtained with Salmonella spp. swine and rabbit antisera 
in the PAST and the tube agglutination tests are presented in 
Table 24. 
PAST titers to B. bronchiseptica obtained with pooled 
nasal wash samples from swine are presented in Table 25. 
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Table 22. Comparison of the particulate antigen settling 
test, tube, plate and microagglutination tests^ 
with swine and rabbit anti-Bordetella bronchiseptica 
serum 
Type of serologic test 
Pipette dilution Microdiluter 
number Species Tube Plate PAST PAST MAT 
1 Swine c 4 512 512 2 
544 Swine 512 512 2048 8192 512 
575 Swine 256 512 1024 2048 32 
576 Swine 16 32 8 
685 Swine — — 32 64 2 
686 Swine 16 16 256 256 8 
691 Swine — —  64 64 4 
693 Swine 2 
694 Swine 4 
633 Rabbit 256 256 2048 8192 512 
634 Rabbit 32 N.D. 2048 
591 Rabbit — N.D. 8 
592 Rabbit — — — N.D. 
^Formalin inactivated B. bronchiseptica (D-1 strain) 
broth culture. 
^Refer to Tables 2 and 3 for history of sample source. 
"^Titer expressed as the reciprocal of the serum dilution. 
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Table 23. Individual serum antibody response in swine from 
Experiments XIII and XIV as determined by the 
particulate antigen settling test and plate 
agglutination^ 
Sample Type of serologic test 
number Treatment of sample source Plate PAST 
70 
71 
74 
167 
168 
171 
231 
233 
239 
241 
621 
626 
631 
632 
Unvaccinated-Unexposed 
32 
2 
2 
2 
8 
2 
4 
82 Unvaccinated-Infected^ 2 32 
85 " " - 64 
86 " " - 32 
87 " " - 32 
204 " " 4 64 
209 " " 2 32 
258 " " 2 256 
259 " " 4 256 
261 " " 4 64 
648 " " 4 256 
649 " " 8 64 
650 " " - 128 
651 .... 4 
661 " " - 32 
662 " " - 64 
664 " " - 32 
666 " " - 16 
^Formalin inactivated B. bronchiseptica (D-1 strain) broth 
culture. 
^Designates if intranasal inoculation of B. bronchiseptica 
(B strain) was conducted. 
CTiter expressed as the reciprocal of the serum dilution. 
Table 23 (Continued) 
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Sample T 'yt/6 of serologic test 
number Treatment of sample source Plate PAST 
687 Unvaccinated-Infected^ 16 
688 tt II 8 32 
689 II il - 32 
690 II ti 32 
623 Sonicate vaccinated-Unexposed^ 256 
624 M fi le 16 1024 
628 91 ei fi 8 256 
629 If f f  n 8 128 
642 Sonicate vaccina ted-^Exposed^ 8 256 
643 •1 W *1 4 128 
644 et »' Il 16 1024 
647 II Il M 8 128 
660 1» I l  I I  16 128 
667 H n M 8 64 
668 M Il II - 16 
670 II Il II 8 64 
Direct hemagglutination inhibition test 
Results obtained with the direct hemagglutination test on 
nasal wash samples obtained from swine are presented in Table 
25. 
Opsonocytophagic test 
The opsonocytophagic test was performed on pooled serum 
and nasal wash samples obtained from several animal experiments. 
The results of these determinations are presented in Table 26. 
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Table 24, Comparison of the particulate antigen settling test, 
tube, and microagglutination tests with swine and 
rabbit anti-Salmonella spp. serum 
Sample. Type of serologic test 
number*^^ Species Antigen Tube PAST MAT 
33 Rabbit S, Virginia H 256^ 256 256 
33 Rabbit s. Virginia H 256 512 512 
NRS^ Rabbit S. Virginia H - - 4 
MRS Rabbit S» Virginia H - - 4 
34 Rabbit S. Virginia 0 64 256 256 
34 Rabbit S. Virginia 0 32 512 128 
NRS Rabbit S. Virginia 0 - - 4 
MRS Rabbit s. Virginia 0 - - 8 
37 Rabbit S. binza H 512 1024 512 
37 Rabbit s. binza H 512 2048 1024 
NRS Rabbit S. binza H - 8 8 
NRS Rabbit s. binza H - 4 -
38 Rabbit S. binza 0 1024 512 256 
38 Rabbit s. binza 0 1024 1024 1024 
NRS Rabbit s. binza 0 - 8 -
NRS Rabbit s. binza 0 - - 4 
614 Swine S. binza H 512 128 128 
614 Swine S. binza H 1024 128 128 
573^ Swine S. binza H 4 16 8 
573 Swine S. binza H 8 8 N.D. 
615 Swine s. binza 0 256 256 128 
615 Swine s. binza 0 128 128 N.D. 
574^ Swine S. binza 0 8 4 -
574 Swine binza 0 8 4 N.D. 
^Refer to Tables 2 and 3 for history of sample source. 
^Titer expressed as the reciprocal of the serum dilution, 
'formal Rabbit Serum (No pre-injection sample available) . 
^Pre-injection serum sample. 
126 
Table 25. Titer of swine nasal wash collections as determined 
by the particulate antigen settling test^ and direct 
hemagglutination inhibition 
Sample Type of serologic test 
number PAST HAI 
308 1*^ -
309 1 1 
310 - -
379 - 1 
380 2 N.D. 
381 32 1 
435 1 1 
436 - 1 
437 1 1 
438 1 2 
442 8 -
443 - -
456 - -
457 2 1 
472 8 -
473 2 -
474 - 1 
475 2 1 
489 - N.D. 
493 - N.D. 
499 - -
500 — -
533 - -
534 4 N.D. 
652 - N.D. 
653 - -
^Formalin inactivated B. bronchiseptica (D-1 strain) broth 
culture. 
^Refer to Table 4 for history of sample source. 
Titer expressed as the reciprocal of the nasal wash 
dilution. 
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Table 26. Results of opsonocytophagic test on pooled sera and 
nasal wash samples 
Averaged opsonocytophagic test values 
Phagocytic Percent 
Sample^ Sample Phagocytosis 
number type B strain D-1 strain B strain D-1 strain 
422 Serum 2^ 2.63 1.73^ 
O
 
o
 
CO 
92.0^ 
1 Serum 13.95^ 24.85^ 100.0^ 97. 0^ 
424a Serum 4. 94^ 14.00^ 86. 0^ 100 . 0 ^  
460a Serum 5.08^ 18.48^ 90. 0^ 100.0^ 
466a Serum 4 .96^ 8.92^ 96. 0^ 98.0^ 
383a Serum 4.18^ 10.80^ 94.0^ 100 .0^ 
142 Serum 9.10^ 21.15^ 86. 0^ 94.0^ 
576 Serum 4.33^ 11.73^ 88. 0^ 98.0^ 
533 Nasal 2.51^ 6.63^ 70 . 5^ 85.0^ 
499 
wash 
Nasal 1.90^ 7. 25^ 59.0^ 83. 0^ 
457 
wash 
Nasal 1. 80^ 10.5^ 68. 0^ 88. 0^ 
500 
wash 
Nasal 2 1.92 6.96^ 70.0^ 87. 0^ 
534 
wash 
Nasal 4.00^ 8.60^ 68. 0^ 88. 0^ 
456 
wash 
Nasal 3.03^ 4.27^ 81.0^ 87.0^ 
442 
wash 
Nasal 
wash 
2. 30^ 21. 40^ 88.0^ 100 .0^ 
^Refer to Tables 2 and 4 for history of sample source. 
^Superscript designates the number of determinations. 
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Bactericidal test 
Nasal and tracheal wash was collected from a pig at 
necropsy on day 107 of Experiment VII. This animal had been 
infected with and had cleared low-virulence B. bronchiseptica 
(D-1 strain) and was resistant to intranasal inoculation by 
virulent B strain. The wash material contained hemoglobin. 
Swine complement was not included in the bactericidal test. 
The nasal and tracheal wash and a tryptose phosphate broth 
control were incubated in separate tubes with B. bronchiseptica 
cells. The nasal wash and tryptose phosphate broth tubes con­
tained 12 colony-forming units per ml while the tracheal wash 
tube contained 14 colony-forming units per ml. 
Nasal wash was obtained from the 4 principal swine in 
Experiment VIII on day 105 and from previously unexposed swine 
of the same age. The 4 principal swine had been infected and 
cleared of low-virulence D-1 strain and were resistant to 
intranasal inoculation by virulent B strain. The nasal washes 
did not contain hemoglobin and were held in an ice bath during 
concentration. The nasal washes were concentrated 2X and 
sterilized by cellulose acetate membrane filtration. No swine 
complement was included in the bactericidal test. Results 
obtained in the bactericidal test with this material are 
presented in Table 27. 
The bactericidal test was performed utilizing guinea pig 
complement with the nasal wash collected on day 105 of 
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Table 27. Results of bactericidal test on pooled sera and 
nasal wash samples 
Sample Sample ^ Averaged colony-forming units 
number type Complement per mililiter 
499 Nasal 
wash 
500 Nasal 
wash 
499 Nasal + 
wash 
500 Nasal + 
wash 
42 2 Serum + 
1 Serum + 
^Refer to Tables 2 and 4 (methods) for history of sample 
source. 
^Indicates if swine complement was added. 
^Superscript designates the number of determinations. 
1 70 
1 66 
34 .00^ 
32 .67^ 
36 .67^ 
12 .67-
Experiment VIII. The average of 3 bactericidal tests conducted 
on different days are presented in Table 27. 
Agglutination of Erythrocytes and Epithelial Cells 
Direct hemagglutination by B. bronchiseptica was investi­
gated because the organism may attach to the respiratory mucosa 
by the same mechanism involved in erythrocyte agglutination. 
It is possible that the ability of the organism to attach to 
cells may explain certain aspects of both the pathogenesis and 
resistance to B. bronchiseptica infection. 
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Bordetella bronchiseptica whole cells hemagglutinated 
swine, human, sheep, and guinea pig erythrocytes. Bordetella 
pertussis whole cells hemagglutinated swine and human erythro­
cytes. Haemophilus spp. hemagglutinated swine erythrocytes 
while Pasteurella multocida, serotype D, did not hemagglutinate 
swine erythrocytes. 
Low-virulence (D-1 strain, 9th passage) and virulent (B 
strain, 9th passage) B. bronchiseptica whole cells were 
harvested from horse blood agar cultures. The D-1 strain 
9 harvest contained 2.3 x 10 colony-forming units per ml and a 
hemagglutination titer of 128. The B strain harvest contained 
2.2 X 10^^ colony-forming units per ml and a hemagglutination 
titer of 64. The hemagglutination titer was found to decrease 
in both the D-1 strain and the B strain on continued passage on 
artificial medium. 
Swine nasal epithelial cells were collected at necropsy 
from a 2-week-old previously unexposed control pig. Concentra­
ted B. bronchiseptica whole cells were mixed with the epithelial 
cells and sheep red blood cells ; and the mixture was incubated 
30 minutes at 37° C. 
The swine nasal epithelial cells which were incubated with 
both B. bronchiseptica whole cells and sheep erythrocytes were 
surrounded by rosettes of erythrocytes when viewed in wet mount 
preparations at lOOx magnification (Figure 11). When swine 
nasal epithelial cells were incubated with only sheep erythro­
cytes, rosette formation did not occur (Figure 12). 
Fi g are 11.. An unstained wet mount preparation containing 
swine nasal cavity epithelial fVl;:- i-iirrounded 
by rosettes of sheep erythroc; • une to the 
presence of Bordetella bronchi: cptica. 430x 
Figure 12. An unstained wet mount preparation containing 
swine nasal cavity epithelial cells and sheep 
erythrocytes. Bordetella bronchiseptica was not 
added to the suspension. 430x 
132 
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Phagocytosis of Bordetella bronchiseptica 
The ability of swine leucocytes to phagocytize 3. bronchi­
septica was determined in order to evaluate certain aspects of 
both pathogenesis and resistance to infection by the organism. 
Bordetella bronchiseptica cells were phagocytized by swine 
polymorphonuclear cells without hyperimmune or normal sera. 
The phagocytic index and percent phagocytosis were calculated 
by averaging the values obtained from 4 determinations conducted 
on different days. The phagocytic index was 3.10 for virulent 
B strain and 11.48 for ] ow-viruJ.Gnce D-1 strain. The percent 
phagocytosis was 82.50 For virulent B strain and 90.25 for low-
virulence D-1 strain. The values of the individual determina­
tions are presented in Table 28, 
Table 28. Results of phagocytosis of virulent (B strain) and 
low-virulence (D-1 strain) B. bronchiseptica by 
swine polymorphonuclear leucocytes 
Phagocytic index 
Percent 
phagocytosis 
Determination B Strain D--1 strain B strain D-1 strain 
1 3.40 11. 30 96.0 93.0 
2 2.00 14.10 66.0 92.0 
3 3.18 11. 54 
O
 
CO C
O
 o
 
CO 
4 3.82 8.98 82.0 88.0 
Average 3.10 11,48** 82.50 90.25^'S 
** 
Significant at p < 0.01 level. 
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DISCUSSION 
Resistance to intranasal infection by B. bronchiseptica 
was induced in pigs by 2 routes of inoculation. Other workers 
have reported the use of immunization procedures to reduce the 
clinical manifestations of pneumonia in swine caused by B. 
bronchiseptica (Phillips, 1944 and Ray, 1950). However, the 
first clear demonstration of the induction of resistance in 
swine to infection by the organism was reported recently and is 
included in this dissertation (Harris and Switzer, 1969). 
Resistance to nasal reinfection by B. bronchiseptica was 
induced in 14 of 14 pigs by clearing the nasal cavity of a 
virulent B strain infection by sulfonamide therapy (Table 9). 
These results suggested that once infected swine had eliminated 
the organism, refractiveness to reinfection occurred. It has 
been reported that exposure of young pigs to virulent B. 
bronchiseptica results in chronic infection (20 weeks) which is 
not readily eliminated from the respiratory tract (Ross, 1965). 
However, Ross et (1967) demonstrated that D-1 strain B. 
bronchiseptica would not cause macroscopic lesions in the 
respiratory tract of young pigs and that the organism was 
eliminated from the respiratory secretions within 4 to 5 weeks 
after initial exposure. In the present study, nasal resistance 
to reinfection was induced in 26 of 26 pigs by infecting them 
with the low-virulence D-1 strain (Table 9). The pigs were 
challenged with virulent B strain after clearance of the D-1 
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strain had occurred. These results contrast with the nasal 
resistance produced in humans by previous infection and 
clearance of Staphylococcus aureus infection. Ehrenkranz (1966) 
demonstrated that once an individual had cleared an infection 
of the organism, the individual was resistant to homologous 
strain but not to heterologous strain challenge. Therefore, 
Ehrenkranz concluded that an immunologic specificity was 
associated with resistance to reinfection in the nasal cavity. 
The antigenic relationship of D-1 and B strain have not been 
determined the 2 strains could be immunologically related 
with regard to resistance. 
Twenty-six,low-virulence D-1 strain cleared,resistant pigs 
were utilized to characterize various parameters of the resist­
ance to reinfection. Nasal resistance persisted despite 
repeated intranasal inoculations of virulent B strain (Experi­
ment III) and continued for at least 125 days after initial 
exposure to the low-virulence D-1 strain (Table 5). Both nasal 
and tracheal resistance to infection by virulent B strain was 
induced by a previous nasal infection with the low-virulence 
D-1 strain (Table 6). No conclusions could be made with regard 
to lung resistance because the virulent B strain did not 
infect the lungs of all positive control swine. Andersen (1953) 
has demonstrated a similar refractiveness to reinfection in 
mice infected with B. pertussis. Mice inoculated intranasally 
with sublethal doses of B. pertussis cleared the organism from 
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their lungs in 59 days. These mice were resistant to reinfec­
tion as determined by culturing the lungs 4- to 8-days after 
challenge with lethal doses of the organism. 
Experiment VII was designed to determine the rate of 
clearance of virulent B strain from resistant pigs and to 
assess the association of the organism with cells of the swine 
nasal cavity. Within 2 to 6 hours after exposure to virulent 
B strain, the pigs had cleared the challenge organisms (Table 
8). One-half hour postinoculation of virulent B strain, 
cultures of centrifuged nasal wash indicated that the organism 
was associated witli nasal cavity cells in 1 resistant pig and 
in 2 control pigs. At 2 and 6 hours postinoculation, the 
organism was associated with nasal cavity cells in the control 
pigs. The technique apparently lacked sensitivity because 
more organisms were occasionally present in the supernatant 
than in the whole nasal washings. This could be explained by 
the multiplication of the organism during the time which expired 
between samples taken for the counts of colony forming units 
from the whole washings and the supernatant. It was not deter­
mined if the B. bronchiseptica organism was associated with 
epithelial, PMN, or mononuclear cells. 
Clearance of the virulent IVDL strain 374 did not occur 
when it was inoculated intranasally into pigs currently in­
fected with the low-virulence D-1 strain (Experiment IX). 
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Apparently, the D-1 strain must be completely eliminated from 
the nasal cavity before the resistance mechanism becomes 
effective. 
Attempts to modify an isolate of D-1 strain by 21 passages 
on artificial media were disappointing (Experiment X). Although 
the atypical colony form of D-1 strain was cleared in approxi­
mately 5 weeks, resistance to reinfection by virulent B strain 
was not induced. The 21st passage of D-1 strain did not clear 
as fast as the low-passage D-1 strain from the nasal cavity of 
pigs and the factors associated with its ability to produce 
resistance were lost. 
Three types of preparations were injected parenterally in 
attempts to produce resistance to B. bronchiseptica nasal in­
fection: these were sonicate-vaccine, pertussis-vaccine and 
whole cell-vaccine. Ganaway et (19 65) reported that in 
guinea pigs both pneumonia and infection of the lungs by B. 
bronchiseptica could be prevented by intramusclar injection of 
formalized bacterin emulsified in Freund incomplete adjuvant. 
Winsser (1960) reported that in mice both mortality and infec­
tion of the lungs by B. bronchiseptica could be prevented by 
the intraperitoneal injection of whole cells inactivated with 
merthiolate. By contrast, intramuscular injection of swine 
with a whole cell-vaccine (B strain) without adjuvant did not 
induce nasal resistance against virulent B strain challenge 
(Experiment XVI). 
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Because of the failure of the whole cell-vaccine (B 
strain) to induce resistance, it was postulated that exposure 
of the pig to the internal antigens of B. bronchiseptica may 
be necessary for the production of resistance to nasal infec­
tion. In preliminary experiments (XI and XII), the sonicate-
vaccine (prepared from D-1 strain) was found to protect against 
intranasal challenge by virulent B strain. However, it was 
apparent that the type of resistance was different from that 
produced in the live low-virulence D-1 strain cleared swine. 
The vaccinated pigs became actively infected with the virulent 
B strain organisms and did not begin to clear the infection for 
21 to 35 days after intranasal inoculation. These experiments 
also indicated that approximately 30 days must elapse after the 
last subcutaneous injection of vaccine before resistance to 
virulent B strain infection would result. 
Experiments XIII and XIV were conducted to determine the 
optimum age for vaccination and the duration of resistance 
induced by the sonicate-vaccine and the pertussis-vaccine. The 
ability to induce nasal resistance to B. bronchiseptica in 
swine with either the sonicate- or pertussis-vaccines was not 
dependent on the aige of the pig at the time of initial injection 
since resistance was successfully produced in pigs from 2-8 
weeks of age (Table 11). 
Pigs, which were inoculated intranasally with the virulent 
organism 35 to 42 days after the first injection of the 
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vaccines, were resistant in 5 of 12 cases in sonicate-vaccine 
injected and in 4 of 12 cases in pertussis-vaccine injected 
pigs when nasal secretions were cultured 35 to 40 days after 
the first intranasal inoculation of virulent B strain (Table 
11). The cultures of nasal secretions collected 61 to 69 days 
after the first intranasal challenge indicated that resistance 
was produced in 9 of 10 cases in sonicate-vaccine injected and 
in 9 of 12 cases in pertussis-vaccine injected pigs (Table 11). 
A high percentage of the unvaccinated infected control pigs 
nasal secretions were consistently positive for the organism. 
In pigs which were inoculated intranasally with the viru­
lent organism 115 to 120 days after the first injection of the 
vaccines, resistance was produced in 2 of 4 cases in sonicate-
vaccine injected and in 3 of 4 cases in pertussis-vaccine in­
jected pigs when nasal secretions were cultured 17 days after 
the first intranasal inoculation of virulent B strain (Table 
12). The results of cultural examination of nasal secretions 
collected 47 days after the first intranasal challenge indicated 
that resistance was produced in all of the sonicate- and 
pertussis-vaccine injected pigs (Table 12). These results indi­
cate that increasing the time between injection of the vaccines 
and intranasal challenge with the virulent B strain elicits 
a more rapid clearance of the organism from the nasal cavity, 
and that a higher percent of the vaccinated animals are pro­
tected against infection as this time interval increases. 
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Statistical analysis revealed that both the sonicate- and the 
pertussis-vaccine induced significant levels of resistance to 
intranasal challenge with virulent B. bronchiseptica (Table 13). 
Protection of swine against infection by B. bronchiseptica 
by injection of a vaccine prepared from B. pertussis is con­
sistent with previous reports concerning cross immunization 
studies in other animals, Evans and Maitland (1939) injected 
guinea pigs with heat killed suspensions of B. pertussis and 
intranasally inoculated them with B. bronchiseptica. Prevention 
of mortality and lung infection caused by the organism was 
demonstrated. Eldering (1942) injected mice subcutaneously 
with merthiolate inactivated whole cells of B. pertussis and 
then challenged hhe mice by intraperitoneal inoculation of B. 
bronchiseptica. Prevention of mortality was demonstrated 
(Table 1). By contrast, Winsser (1960) attempted immunization 
of mice with merthiolate inactivated B. pertussis whole cell 
vaccines injected intraperitoneally. The vaccinated mice were 
not protected against mortality caused by the intranasal inocu­
lation of B. bronchiseptica, and the organism was recovered 
from the lungs. Kendrick e^ (1953) and Ross et a]^. (1969) 
reported that the intraperitoneal injection of B. pertussis 
whole cell vaccines protected mice against mortality caused by 
the intracerebral inoculation of B. bronchiseptica. 
The protection of swine against infection by B. bronchi­
septica by the injection of a vaccine prepared by the sonication 
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of the organism was comparable to the immunization studies in 
mice conducted by other workers. Eldering (1941) injected 
mice subcutaneously with lipopolysaccharide fractions of B. 
bronchiseptica and challenged with the organism by intra­
peritoneal inoculation. Prevention of mortality was demon­
strated (Table 1). Ross et a^. (1969) injected mice intra-
peritoneally with a saline extract of mechanically disrupted 
B. bronchiseptica and demonstrated protection against mortality 
when the mice were challenged intracerebrally with the organism. 
The protective antigens contained in the lipopolysaccharide 
fractions of Eldering (19 41) and in the saline extract of Ross 
et al. (1969) were possibly the same as the antigens present in 
the sonicate-vaccine. The results of the current study of the 
active immunization of pigs by the injection of vaccines indi­
cate that vaccines similar to those with the capability of pro­
tecting mice against mortality somehow induce a resistance to 
infection of the swiae nasal cavity by B. bronchiseptica. This 
resistance to infection, however, was net manifested by a com­
plete refractiveness to the challenge organisms soon after 
intranasal inoculation since 40 to 60 days were required for 
the clearance of virulent B. bronchiseptica. This was not the 
case in the low-virulence D-1 strain cleared resistant swine 
since they were capable of elimination of virulent B. bronchi­
septica in 2-6 hours after challenge. Apparently, the vaccine 
does not prevent infection but actually allows the pig to 
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develop a resistance which eliminates the infection faster than 
in unvaccinated control pigs. Possibly, the correlation between 
protection against mortality in mice and nasal resistance to 
infection in swine can be explained by postulating that the vac­
cine actually prevents damage to the respiratory mucosa which 
allows the pig to eliminate the infection by activation of its 
own local respiratory tract defense mechanisms. 
Dolby et al. (1961) demonstrated that B. pertussis was 
present initially but disappeared from the lungs of immunized 
mice within 28 days after vaccination. These mice were 
immunized with a vaccine which protected against mortality 
caused by intracerebral inoculation. Such results are consist­
ent with the current observations on nasal resistance in swine 
immunized with either sonicate- or pertussis-vaccine. 
The attempts to clear virulent B strain infection from 
swine by injection of pertussis-vaccine 7 days after initial 
intranasal exposure were not successful (Experiment XV) . As in 
the case of the D-1 strain cleared resistance, it appears that 
the pig must be free of the virulent strain at the time of vac­
cination for successful development of resistance. 
As discussed earlier, the trial (Experiment XVI) using a 
formalin inactivated whole cell-vaccine prepared from B strain 
to protect pigs against intranasal inoculation of B strain did 
not produce resistance. This finding is inconsistent with the 
results of Ganaway et al. (1965) and Winsser (1960). Therefore, 
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Experiment XVII was planned to supplement the observations in 
the previous experiment. In Experiment XVII, the 4 swine in­
jected subcutaneously with a formalin inactivated whole cell-
vaccine prepared from D-1 strain cleared the virulent B strain 
by 60 days after the first exposure to the challenge organisms 
(Table 14). 
Several differences existed between Experiment XVI and 
XVII any one of which could explain the variation in results. 
The whole cell-vaccines were prepared from 2 different strains 
with the same concentration of formalin used for inactivation. 
However, the B strain bacterin was inactivated by incubation at 
room temperature and the D-1 strain bacterin was inactivated by 
incubation at refrigerator temperature. The B strain bacterin 
was not mixed with adjuvant and was injected intramuscularly. 
The D-1 strain bacterin was mixed with Freund incomplete 
adjuvant and was injected subcutaneously. The interval of 
time elapsing between the last injection of the B strain bac­
terin and challenge was 8 days while 32 days elapsed in the 
case of the D-1 strain bacterin. Additional trials will be 
necessary to clarify the variation in the results of these 2 
experiments. 
Bordetella bronchiseptica may infect the pig nasal cavity 
as early as 48 hours after birth (Harris and Switzer, 1968), 
The types of resistance which have been described thus far 
require a time interval of several days before challenge by 
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virulent organisms and do not clear the organism if immuniza­
tion is attempted during an active infection. Since these 
types have serious practical limitations, an attempt was made 
to produce passive resistance by immunization of pregnant sows. 
Results of Experiments XVIII, XIX, XX, and XXI indicated 
that sonicate-vaccine which was capable of eliciting active 
nasal resistance in young pigs would not induce either resist­
ance to intranasal infection by virulent B strain or prevent 
the development of lesions in the respiratory tract of passively 
immunized pigs (Tables 15 and 16). There was, however, a 
decrease in the number of tracheas and lungs positive for the 
organism in pigs from vaccinated sows as opposed to unvaccinated 
sows. Five of 12 pigs from unvaccinated sows had lesions of 
pneumonia while 0 of 14 pigs from vaccinated sows had lung 
lesions. The mechanism which allows production of nasal resist­
ance in pigs following active immunization was not induced in 
passively immunized pigs born of sows injected with sonicate-
vaccine. 
The trial comparing the influence of the age of pigs at 
the time of first intranasal exposure to virulent B. bronchi-
septica B strain on the duration of infection is of interest 
(Table 17). The 24-week-old pigs became infected with the 
organism but cleared the infection by 33 days postinoculation 
at which time the 3-week-old pigs were still infected. Because 
the clearance of the B strain from 24-week-old pigs resembled 
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the clearance of D-1 strain from young pigs, 2 of the B strain 
cleared pigs were challenged with B strain organisms. The 
nasal secretions of these pigs were negative for the organism 
7 days postinoculation; however, the secretions ccrta.i.ned the 
organism when the pigs were necropsied 9 days '-'ostinoculation. 
This suggests that clearance of B strain from the nasal cavity 
may not result in the inducement of nasal resistance of the 
magnitude elicited by the clearance of D-1 strain. 
The results of Experiment VI indicated that some mild 
damage to the turbinate was caused by the low-virulence D-1 
strain infection; however, the damage was mild as compared to 
infection by virulent B strain. The cellular response occurring 
in the lamina propria of the turbinates of D-1 strain infected 
and/or cleared swine consisted of a mild diffuse infiltration 
of mononuclear cells. VJhen these pigs were c lea red of the D-1 
strain infection and then inoculated intranasally with virulent 
B strain, focal accumulations of mononuclear cells were present 
in the lamina propria of resistant pigs when necropsied 1 week 
postinoculation (Experiment V). The epithelium of these resist­
ant pigs appeared normal. The turbinates of the control swine 
which were inoculated intranasally with B strain and necropsied 
at the same time did not contain mononuclear cell infiltrate 
but had hyperplasia of the epithelium. 
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In other experiments, the positive control swine were not 
necropsied until 30 to 60 days after inoculation of the 
virulent B strain. In many of these pigs, focal accumulations 
of mononuclear cells occurred in the lamina propria which was 
consistent with the observations of Duncan (1965). In the 
experiments in which resistance was produced by injections of 
either sonicate- or pertussis-vaccines, massive focal accumula­
tions of mononuclear cells occurred in the turbinate lamina 
propria of most pigs. In some pigs these accumulations re­
sembled lymph node follicles, A majority of mononuclear cells 
in the focal accumulations were pyroninophilic in either 
positive control or resistant pigs. Occasionally in both 
positive control and resistant pigs the mononuclear cells were 
observed in close association with the epitheliU'T and appeared 
to be migrating through the epithelium. The pvroninophilic 
nature of these cells would indicate active protein synthesis 
associated either with cellular proliferation or with the pro­
duction of proteins for humoral secretion. Berenbaum et al,. 
(19 60) reported that the brains of pertussis vaccinated mice 
contained an intense focal mononuclear cell response which was 
associated with the elimination of B. pertussis infection after 
intracerebral challenge inoculation. 
Possibly, focal accumulation of monocytes is associated 
with an immunologic mechanism which may explain the rapid and 
complete resistance in the D-1 strain cleared swine, the 
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development of the ability to clear the infection in sonicate-
vaccine and pertussis-vaccine injected swine, and the gradual 
clearance of the infection in positive control swine, This 
immunologic mechanism could be of a cellular and/C'.. humoral 
nature. 
The antibody titers present in the serum of pigs during 
the course of an experiment were determined by the PAST. Titers 
of antibody were detectable from the serum of pigs which were 
infected with low-virulence D-1 strain B. bronchiseptica but 
were rarely hiclv.'îr than 32 and some pigs did not have a detect­
able level. The serum titers of antibody in resistant pigs 
were not increased upon challenge inoculation with virulent B 
strain. B strain infected pig serum antibody titers were of 
the same magnitude as the antibody titers from pigs which were 
infected with the D-1 strain. 
The serum antibody titers of the positive control pigs in 
Experiment XIII indicated that higher responses were stimulated 
by increasing the age of the pigs at the time of the first 
intranasal inoculation with the virulent B strain (Figure 4). 
The titers tended to peak at 2 week postinoculation and to 
decrease from then on. The sera of the baby pigs in Experiments 
XVIII and XIX exhibited titers up to 32 at 3 rlnvs of age before 
intranasal inoculation of the virulent B strain which was 
attributed to a non-specific reaction since sera from these 
pigs then consistently remained negative for antibody for 
several weeks postinoculation. 
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The detection of antibody in the sera of experimentally 
infected pigs was consistent with the observations oi Ross 
(1965), who, (as in Experiments XVIII and XIX when 3-day-old 
pigs were inoculated with virulent organisms) did not detect 
agglutinins in the serum of pigs until 20 weeks postinoculation 
while pigs inoculated with virulent strain at 4 weeks of age, 
developed detectable agglutinins with the tube agglutination 
test at 6 to 8 weeks postinoculation. 
High serum antibody titers were present in pigs injected 
with sonicate- and pertussis-vaccine, with whole cell-vaccines 
(B and D-1 strain) and in pigs receiving colostrum from sows 
injected with sonicate-vaccine (Figures 4, 5, 8, and 9). The 
serum antibody titers in sonicate- and pertussis-vaccine and 
in D-1 strain whole cell-vaccine injected pigs remained rather 
constant during infection wiL-h v6^ulent B strain. At the time 
of clearance of the infection the titers were usually increased. 
However, this was not the case with pigs injected with sonicate-
vaccine at 2 weeks of age (Figure 4). 
The results of the determinations of the antibody titers 
with the PAST indicate that serum antibody was not associated 
with resistance to intranasal infection. This was evident 
because low or undetectable levels of antibody were present in 
the D-1 strain cleared swine which were resistant to challenge 
inoculation. By contrast, the pigs receiving sonicate- and 
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pertussis-vaccine had high serum antibody titers but became 
infected initially when inoculated intranasally with virulent 
B strain. It seems likely that the agglutinogen(s) are not 
responsible for induction of protection. By comparison, Holt 
and Spasojevic (1968) reported that vaccines, prepared from 
B. pertussis strains which did not possess agglutinogens, 
protected mice against intracerebral challenge by B. pertussis. 
Antibodies were demonstrated by the PAST in concentrated 
nasal washings collected from pigs cleared of D-1 strain, from 
D-1 cleared pigs which had resisted B strain challenge, from 
pigs infected with B strain, and from pigs injected with soni­
cate-vaccine both before and after B strain challenge (Table 
25). With the detection of antibody in the nasal washings, an 
effort was made to determine the significance of these anti­
bodies and to associate them with resistance to infection by 
B. bronchiseptica. 
It was demonstrated ^  vitro that swine nasal epithelial 
cells attached to the B. bronchiseptica organism with the 
formation of rosettes of erythrocytes around the epithelial 
cells. It appeared that the organisms were bridging and con­
necting the epithelial cells to the erythrocytes. It is 
believed that Tartakowsky (1898) first described the close 
affinity with which the B. bronchiseptica cells adhered to the 
respiratory tract epithelium of the guinea pig (Smith, 1913). 
However, no ^  vitro studies with either B. bronchiseptica or 
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B. pertussis have been reported which have assessed the role 
of specific attachment as an invasive mechanism. 
The attachment to tracheal epithelial cells by Mycoplasma 
pneumoniae has recently been demonstrated (Sobeslavsky et , 
1968 and Lipman and Clyde, 1969). Sobeslavsky et a^. (1968) 
reported that the receptors on erythrocytes were neuraminic 
acid and that the same receptor sites for M. pneumoniae were 
present on the tracheal epithelial cell. Lamb and Reid (1968) 
demonstrated sialomucin in rat respiratory tract secretions. 
Antibody or sialomucin may have the capacity to block the 
attachment sites present on certain infectious agents and pre­
vent their attachment to respiratory tract epithelial cells. 
The attachment site blocked infectious particles could then be 
eliminated as inert particles by the mucociliary apparatus. 
Based on this information, it was postulated that sub­
stances may be present in the nasal washings from pigs which 
would inhibit agglutination of erythrocytes by B. bronchi-
septica. Such an inhibition of attachment to nasal and tracheal 
epithelial cells would be a mechanism which would explain the 
production of resistance to infection. 
The direct hemagglutination-inhibition test was performed 
with the concentrated nasal wash samples. Substances were 
present which inhibited agglutination of erythrocytes in the 
nasal washings of D-1 strain cleared pigs, of D-1 cleared and 
exposed to B strain pigs, of B strain exposed pigs, and of pigs 
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injected with sonicate-vaccine and exposed to B strain (Table 
25). The direct hemagglutination-inhibition test was quite 
variable on repeat determinations. Some nasal washings from 
unexposed, unvaccinated swine contained hemagglutination-
inhibiting substances; however, the titers of the inhibitory 
substances from infected or resistant swine were of a higher 
magnitude. 
The data indicating the presence of antibody either by the 
PAST or the HAI test in nasal washings was considered to be too 
preliminary for final conclusions. The possibility that sub­
stances may be stimulated in resistant or infected pigs which 
inhibit the attachment of B. bironchiseptica to the epithelial 
cells needs further investigation. For example, it would be 
logical for the B strain infection of pigs to stimulate sub­
stances (antibody) which wou]d i.rjhibit epithelial cell attach­
ment. However, if the mucociliary apparatus was damaged due to 
an infection, then the substances would not prevent coloniza­
tion of damaged, cilia denuded, portions of the mucosa. In the 
D-1 cleared pigs, when the mucociliary apparatus was quite 
functional, substances could have inhibited epithelial cell 
attachment by the organism. The organism would then be removed 
by the host's natural defense mechanism, the mucociliary 
apparatus. 
A similar explanation for the resistance induced by 
sonicate- and pertussis-vaccine and the D-1 strain whole cell-
vaccine can be proposed. In such types of nasal resistance, 
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the action of the vaccines would be to prevent damage caused 
by the organism to the mucociliary apparatus. In this way, 
the presence of the organism for 30 to 60 days following intra­
nasal inoculation .would stimulate the inhibitory substances 
necessary for prevention of attachment to the epithelial cells. 
The above working hypothesis is suggested to aid future research 
on the definition of the mechanism of nasal resistance to B. 
bronchiseptica infection. 
This hypothesis gains indirect support from experiments 
conducted in mice with regard to resistance to lung infection 
by B. pertussis. Dolby and Dolby (1969) injected rabbits with 
B. pertussis vaccine. Fractions of the antisera were incubated 
with inoculum which consisted of lethal numbers of organisms 
for intracerebral challenge and of sub-lethal numbers of 
organisms for intranasal challenge in mice. Resistance was 
evaluated by brain and lung counts of B. pertussis. The serum 
fraction associated with the maximum bactericidal activity in 
vitro conferred resistance to intracerebral challenge. How­
ever, the fraction associated with hemagglutination-inhibition 
activity vitro was correlated with resistance to intranasal 
challenge. 
Masry (1952) reported that the passive injection of anti-
hemagglutinin would not protect mice against mortality when 
challenged with lethal doses of B. pertussis either by the 
intracerebral or intranasal route. However, this method of 
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administration would not necessarily result in anti-hemagglu-
tinin being present in the respiratory secretions. Also, such 
receptor blockage by anti-hemagglutinin would not be of value 
in the intracerebral challenge test. 
These results of Masry (1952) have received considerable 
prominence as indicators that anti-hemagglutinin is not in­
volved in protection of mice against intranasal challenge. The 
results obtained in the present study suggest that this classi­
cal work must be reevaluated. Anti-hemagglutinin, 
when present in nasal secretions, may be a major resistance 
mechanism to protect the nasal epithelium against Bordetella 
attachment and colonization. 
Experiments were conducted with pooled serum and nasal 
washings using the opsonocytophagic test and the bactericidal 
test (Tables 26 and 27) . Serum and nasal wash samples con­
taining antibody to B. bronchiseptica, detectable by the PAST 
with D-1 strain as the test organism, gave higher phagocytic 
index and percent phagocytosis values than with B strain as the 
test organism. The D-1 strain appeared to be a more sensitive 
indicator than B strain for detecting the presence of opsonins 
from various samples. 
The pooled serum samples from pigs injected with the 4 
types of vaccines increased the phagocytic index (D-1 strain) 
more than 12 units as compared to the serum from unexposed, 
unvaccinated pigs. The pooled serum samples from D-1 strain 
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cleared pigs, and from D-1 strain cleared and exposed to B 
strain pigs increased the phagocytic index (D-1 strain) by 
more than 6 units as compared to serum from unexposed, unvac-
cinated pigs. By contrast, serum from pigs injected with B 
strain whole cell-vaccine and sonicate-vaccine increased the 
phagocytic index (B strain) by only 6 units. All other sera 
tested produced less than 6 units difference as compared to 
unexposed, unvaccinated pig serum for the phagocytic index 
conducted with B strain as the test organism. 
One of 3 pooled nasal samples from D-1 cleared and exposed 
to B strain pigs, and 1 of 1 comparable samples from pigs 
injected with sonicate-vaccine increased the phagocytic index 
(D-1 strain) by more than 3 units as compared to nasal wash 
samples from unexposed, unvaccinated control swine. Very small 
increases in the phagocytic index occurred when B strain was 
used as the test organism. 
It was concluded that opsonins present in the sera or 
nasal washings of the D-1 strain cleared and vaccinated swine 
were not correlated with respiratory resistance. This was 
illustrated by the rather high titer of opsonin in the sera 
from pigs injected with B strain whole cell-vaccine even though 
the pigs were not resistant to challenge inoculation. Also, 
the pooled nasal wash from sonicate-vaccine injected pigs 
contained a high titer of opsonin before challenge with 
virulent B strain. Such pigs become infected initially when 
challenged with B strain. 
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The pooled serum sample from pigs injected with B strain 
whole cell-vaccine was bactericidal as compared to the serum 
from exposed, unvaccinated pigs (Table 27), The pooled nasal 
wash sample from D-1 strain cleared and B strain exposed pigs 
was not bactericidal when used either in the presence or 
absence of swine complement. Based on these preliminary experi­
ments, it appeared that bactericidal substances were probably 
not involved in the induction of resistance to nasal infection 
by B. bronchiseptica. However, more trials with a greater 
number of samples would be necessary before reaching a definite 
conclusion. 
Direct hemagglutination by various respiratory tract 
pathogenic bacteria was investigated because these organisms 
may attach to the respiratory mucosa by the same mechanism 
involved in erythrocyte agglutination. Bordetella bronchisep­
tica and Haemophilus spp. readily infect the swine nassl 
cavity when inoculated into experimental swine. Pasteurella 
multocida does not readily establish a primary infection. 
Harris and Switzer (196B) have shown that preconditioning of 
the nasal epithelium with B. bronchiseptica infection results 
in the establishment of P. fu]. to ci da infection. The results of 
the hemagglutination studies indicate a correlation between the 
ability of a microorganism to establish a primary infection 
and to agglutinate erythrocytes. Further research character­
izing the nature of the attachment sites on epithelial cells 
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should be conducted to expand and develop this preliminary-
observation since it may be of prime importance in under­
standing the pathogenesis of bacterial infections of the res­
piratory tract. 
It is of interest that the low-virulence D-1 strain 
possessed more hemagglutinin per cell than the virulent B 
strain. This could allow an increased local production of anti-
hemagglutinin in the nasal secretions of the resistant pigs 
which have cleared the D-1 strain. The present studies have 
also demonstrated that B. bronchiseptica agglutinates swine, 
human, sheep, and guinea pig erythrocytes and that B. pertussis 
agglutinates swine and human erythrocytes. It has been pre­
viously reported that B. bronchiseptica and B. pertussis agglu­
tinate human, mouse, and fowl erythrocytes (Keogh et al., 
1947) . It has also been reported that B. bronchiseptica agglu­
tinates sheep (Joubert et , 1960) , horse and parakeet 
(Gallagher, 1965) erythrocytes. 
The results of the phagocytosis studies of the 2 strains 
of B. bronchiseptica by swine PMN leucocytes indicated a statis­
tically significant increase (at the 0.01 probability level) 
in the phagocytic index obtained with the low-virulence D-1 
strain as opposed to the virulent B strain (Table 28). The 
PMN leucocytes present in the nasal cavity of the pigs infected 
with the D-1 strain should more effectively remove this organ­
ism than the B strain from the mucosa. This may be the 
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mechanism responsible for the natural clearance of this strain 
from the nasal cavity more rapidly than the B strain. 
An attempt was made to critically evaluate the Particulate 
Antigen Settling Test (PAST) for its usefulness as a routine 
serological test. Initially, a problem with non-specific posi­
tive reactions occurred with sera from unexposed, unvaccinated 
pigs. The non-specific reaction could be decreased by the use 
of 5 percent NaCl as diluent without appreciable reduction in 
the antibody titers of serum from either infected or vaccinated 
pigs (Table 18). Ninety-three serum samples from unexposed, 
unvaccinated swine of various ages were titrated for antibody 
during this study (Table 19). Eighty of these samples contained 
non-specific reactions at the 1 to 4 dilution or less. Pigs 
which were 3 days of age, or over 16 weeks of age had sera with 
the most non-specific reactions. Antigens prepared in broth, 
either inactivated or live, appeared to be the most sensitive 
indicator of antibody titer (Table 20). The formalin in­
activated antigen prepared from D-1 strain was utilized because 
of its greater stability as compared to live antigen prepara­
tions and its increased sensitivity over antigens prepared from 
B strain. 
The reproducibility within lots and between different lots 
of D-1 strain inactivated broth antigen was determined (Table 
21). The reproducibility within a lot of antigen usually 
varied by less than a 1-fold dilution. The reproducibility 
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between lots of antigens was more erratic in that a 4-fold 
dilution variation occurred with some serum samples. 
The comparison of the titers of swine and rabbit sera in 
the tube, plate, PAST, and MAT revealed that the PAST was more 
sensitive than the other types of test lex •? and 23). 
Sv/ine or rabbits which had been intranasal!;/ >osed to or 
received injections of B strain B, bronchisept.ica exhibited 
the greatest difference in titers, ranging from 3- to 6-fold 
dilutions. The difference in titers in animals receiving ho­
mologous antigen exposure (D-1 strain) were increased by 2- to 
6-fold dilutions. These results disagree somewhat with those 
reported by other workers. Beneson et (1968) reported that 
antibody titers in human patients infected with Vibrio cholerac 
were lower by 2- to 3-fold dilutions in a similar microtechnique 
test than in the tube agglutination test. Their results indi­
cated that sera tested with a heterologous antigen gave a 
similar titer in either tent. 
The comparison of titers present in swine and rabbit sera 
containing antibody to Salmonella spp. antigens by the tube, 
PAST, and MAT indicated a very small variation in titer between 
tests (Table 24). It was concluded that the reason for the 
increased sensitivity of the PAST with B. bronchiseptica anti­
gens was because the agglutinated clumps of antigen were 
mechanically broken up in the reading of the tube test and the 
MAT, whereas in the PAST, the antigen and antibody settled to 
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the bottom of the well and was not disturbed physically before 
reading the test. 
Another reason for the increased sensitivity was explained 
by the comparison in which the serum was diluted with either 
pipettes or microdiluters (Table 22). Some serum samples had a 
4-fold increase in titer by the use of the microdiluters as 
compared to pipette dilutions in the PAST. Hirata et al. (1959) 
has reported that microdiluters may cause exaggerated passive 
hemagglutination titers. 
The PAST was used for the detection of infection by B. 
bronchiseptica in experimental swine (Table 23). Of the 21 
unvaccinated, exposed control swine serum samples, 20 pigs con­
tained titers of 8 or more in the PAST as compared to only 2 
samples with titers detectable in the plate agglutination test. 
Utilization of the PAST for detection of infected pigs in the 
field is a possibility. However, the detection of the nasal 
carriers of B. bronchiseptica is more easily accomplished by 
bacteriologic culturing. 
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